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Abstract
Type 2 diabetes mellitus (T2DM) and colorectal cancer (CRC) are 2 chronic diseases
with common risk factors related to physical inactivity, obesity, and diet. Literature on
T2DM as a risk factor for CRC development and survival in Oman is scarce. Using deidentified archival data provided by Sultan Qaboos University Hospital (SQUH) Oman, a
retrospective, case-control, and time-to-event study designs were used to compare odds
of developing CRC, and survival rates among adults with and without T2DM. The
ecosocial theory provided the theoretical base for this research. Logistic regression was
used to examine the odds of developing CRC among 114 cases versus 170 hospital
controls. The Cox proportional hazards regression was used to compare survival rates
among 228 CRC cases by T2DM status and survival rates by T2DM status across strata
of gender, age group, and tumor location and cancer stage. According to the study
findings, after having adjusted for potential confounding variables, there was no
association between T2DM and odds of developing CRC (OR = 1.49, 95% CI: 0.29-7.68,
p = 0.64) or between T2DM and CRC survival rates (HR = 1.07, 95% CI: 0.65 -1.75, p =
0.80). There was also no association between T2DM and CRC survival rates across the
strata of potential effect modifiers examined. This research could contribute to positive
social change by creating awareness among policy makers that will provide them with
information on CRC risk-reduction strategies in the Omani population.
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Chapter 1: Introduction to the Study
Type 2 diabetes mellitus (T2DM) and colorectal cancer (CRC) are two chronic
diseases with common risk factors related to diet and lifestyle, such as obesity, smoking,
alcohol consumption, high consumption of red and processed meat, a diet low in fruits
and vegetables, and physical inactivity (Haq, Ali, Mohammad, & Sarkar, 2012;
MacFarlane & Stover, 2007; Yu, Zou, & Dong, 2014). In results from epidemiological
studies conducted in Western countries, scholars have suggested that there is a
relationship between diabetes and the risk and prognosis of certain cancers, such as
breast, prostate, colorectal, and pancreatic cancers (De Bruijn et al., 2013; Ferroni et al.,
2015; Luo, Lin, He, & Hendryx, 2014). However, research findings based on Western
populations may not be applicable to Arab populations, such as the Omani population.
For example, in genetic studies on a sample of Omani CRC patients, Ashktorab et al.
(2008) showed that abnormalities in mismatched repair genes differed from similar
studies in other populations. Moreover, similar studies on T2DM and CRC in Arab
populations are scarce. Therefore, studying the association between T2DM and CRC in
the Omani population presents an area of research that could fill this knowledge gap.
The focus of this research was on the association between T2DM and CRC risk
and survival in the Omani population. The findings from this research may provide a
better understanding of the association between T2DM and CRC risk and survival. First,
findings from this research may help increase awareness about the risk of CRC in the
Omani population. Secondly, the findings can guide the design of preventive
interventions that are tailored towards the Arab or Omani population, thus contributing to
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positive social change. Thirdly, preventive measures to address the burden of CRC could
lead to a reduction in the direct and indirect costs associated with CRC diagnosis and
treatment in Oman
The proceeding sections of this chapter include the background of this research, a
statement of the problem, the study design and purpose, research questions, conceptual
framework, definition of terms, assumptions, limitations and scope, and the significance
of the study.
Background of the Study
The Sultanate of Oman is a country that occupies the South Eastern corner of the
Arabian Peninsula and has a total area of 309 500 km2 (World Population Review, 2016).
It is bordered in the northwest by the United Arab Emirates, in the west by Saudi Arabia,
and in the southwest by Yemen, and has an estimated population of 4.91 million (World
Health Organization [WHO], 2016a). Nearly 50% of the population lives in Muscat, the
capital city, which happens to be the largest city in the country (World Population
Review, 2016). Oman belongs to the Cooperation Council for the Arab States of the Gulf,
a political and economic union of six Arab countries known as the GCC countries. Others
are Saudi Arabia, Bahrain, Qatar, United Arab Emirates, and Kuwait. These countries
share similar psychosocial characteristics and have been ranked among the top countries
with the highest diabetes prevalence in the Middle East and North Africa (MENA) region
by the International Diabetes Federation (IDF, 2015).
Diabetes mellitus (DM) is a metabolic disorder of multiple etiologies, related to
carbohydrate, fat, and protein metabolism. The hallmark of diabetes is hyperglycemia.
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There are two main types of diabetes: Type 1 and T2DM. T2DM is the more common
type, representing 90% of all diabetic cases worldwide (IDF, 2015; WHO, 2010). It
develops in adulthood and is related to lack of physical activity, unhealthy diets, obesity,
and insulin resistance (WHO, 2010). Insulin resistance is a common compensatory
mechanism in obese individuals, characterized by hyperglycemia, which ultimately leads
to T2DM (De Bruijn et al., 2013). With rising obesity worldwide, the incidence of T2DM
is likely to increase (Al Hakmani et al., 2016).
T2DM is a growing public health problem that affects multiple organ systems in
the body and reduces health-related quality of life and overall life expectancy. In 2015,
T2DM accounted for 14.5% of all-cause mortality among adults 20-70 years of age
globally, and more than half of these deaths occurred in persons below the age of 60
years (IDF, 2015). According to the IDF (2015), the high rates of diabetes in Oman may
be attributed to the epidemiological transition that has occurred in the country following
crude oil discovery in the 1970s; rapid socioeconomic development and good health care
planning led to a decline in various communicable diseases, but presented new challenges
in the form of lifestyle-related, noncommunicable diseases like diabetes and cancer (Al
Shookri, Khor, Chan, Loke, & Al-Maskari, 2011). From 1991 to 2000, the prevalence of
T2DM in Oman rose from 8.3% to 11.6 % (Al Shookri et al., 2011). About 12% of the
Omani population in 2010 had diabetes, alongside other risk factors, such as obesity,
overweight, and insulin resistance (Al Riyami, 2010). According to Al Nohair (2014),
this rise in T2DM prevalence is likely due to changes in food consumption,
socioeconomic and demographic factors, physical inactivity, and urbanization over the
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past 3 decades. In 2010, T2DM was the fourth leading cause of premature death in Oman
after ischemic heart disease, mental disorders, and musculoskeletal diseases (Mokdad et
al., 2014). This is in addition to the economic burden of diabetes management. According
to the IDF, the annual cost per person for managing diabetes in 2015 in Oman was over
1,000 U.S. dollars (IDF, 2015).
CRC is among the most common causes of cancer-related morbidity and mortality
worldwide. In 2013, CRC accounted for 1.6 million of the 14.9 million global incident
cancer cases (Global Burden of Disease Cancer Collaboration, 2015). Within the same
period, CRC was responsible for more than 700,000 of the total 8.2 million cancer-related
deaths (Global Burden of Disease Cancer Collaboration, 2015). CRC currently ranks as
the third most common cancer in the world and the fourth in cancer-related deaths after
lung and breast cancers respectively (Global Burden of Disease Cancer Collaboration,
2015). Although the incidence rates for CRC are higher in more developed countries like
Australia, countries in Western Europe, North America, and high-income Asia-Pacific
countries (Global Burden of Disease Cancer Collaboration, 2015; Hakulinen, 2007), the
Middle Eastern countries, such as Oman, have been witnessing a rising trend over the
past decade due to the adoption of Westernized diets and lifestyle (Al Mahrouqi, Parkin,
& Sharples, 2011; Brim et al., 2008; Muliira, D’Souza, & Ahmed, 2016). The WHO
(2014) indicated that CRC is the most frequent cancer among Omani men, and the third
most common in Omani women with incidence rates of 10.2 and 8.5 per 100,000 cases
for men and women respectively. CRC accounted for 9.0% of all-cause mortality in adult
Omani males and 8.3% in females in the same period (WHO, 2014).
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Many scholars have examined the association between diabetes and CRC (De
Bruijn et al., 2013; Ferroni et al., 2015; Larsson, Orsini, & Wolk, 2005; Trabulo et al.,
2015). Researchers have suggested that impaired glucose metabolism, hyperinsulinemia,
insulin resistance, and obesity-related proinflamatory conditions, as well as
hyperinsulinemia–related increases in insulin-like Growth Factor-1 and 3 (IGF-1 and
IGF-3), play a key role. T2DM typically develops following long-term insulin resistance
whereby higher concentrations of endogenous insulin are required for the normal use of
circulating glucose. The resulting chronic hyperinsulinemia triggers a chain of metabolic
responses involving a reduction in the circulating levels of insulin-like growth factor
binding protein-1(IGFBP-1) and an increased tissue availability of IGF -1 and IGF-3 (De
Bruijn et al., 2013; Ferroni et al., 2015; Larsson et al., 2005; Trabulo et al., 2015).
Hyperinsulinemia in the presence of lower levels of circulating IGFBP-1 has been shown
to increase CRC risk in prospective observational studies (Larsson et al., 2005; Trabulo et
al., 2015). Chronic proinflamatory conditions and reactive oxygen species (ROS) have
also been implicated. ROS invariably promotes tumor growth and proliferation via cell
and tissue damage (De Bruijn et al., 2013; Ferroni et al., 2015). Hence, the inflammatory
interplay between dysregulated glucose metabolism characteristic of T2DM, the release
of cytokines and reactive oxygen species from adipose tissues, and the dysregulation of
growth signals involving insulin and IGF-1 present a favorable milieu for colorectal
carcinogenesis (K.H. Chen et al., 2014; Giovannucci & Michaud, 2007; Jeon et al.,
2013).
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Although scholars have examined the association between T2DM and CRC risk
and mortality (De Bruijn et al., 2013; Ferroni et al., 2015; Krämer, Schöttker, Raum, &
Brenner, 2012; Luo et al., 2014), there is a paucity of data on the Arab population of the
Middle East, such as Oman. This gap in the literature, coupled with the burden of both
T2DM and CRC in Oman, provided the basis for this research. This research will
contribute to positive social change by providing a better understanding of the association
between T2DM and CRC risk and survival in the Omani population and inform the
design of preventive and health promotion strategies
Problem Statement
T2DM and CRC are two diseases with shared risk factors related to diet and
lifestyle, such as obesity, smoking, alcohol consumption, high consumption of red and
processed meat, a diet low in fruits and vegetables, and a sedentary lifestyle (Brim et al.,
2008; Haq et al., 2012; MacFarlane & Stover, 2007; Yu et al., 2014). About 12% of the
Omani population lives with T2DM, alongside other risk factors such as obesity,
overweight, and insulin resistance (Al Riyami, 2010). This rise in T2DM and associated
risk factors has been attributed to increased inactivity due to the availability and use of
technologies such as cars, elevators, and other automated household devices, plus an
inclination for Westernized diets of processed and semi processed foods that are rich in
saturated fats among many Omanis (Al Shookri et al., 2011; Goh, 2007; Mahfouz, Sadek,
Abdel-Latief, Mosallem, & Hassan, 2014; Muliira et al., 2016).
In epidemiological studies in the West, researchers have indicated that there is a
link between T2DM and CRC (K.H. Chen et al., 2014; Dehal et al., 2012; Deng, Gui,
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Zhao, Wang, & Shen, 2012; Erbach, Mehnert, & Schnell, 2012; Huang et al., 2011; Jeon
et al., 2013; Jullumstrø, Kollind, Lydersen, & Edna, 2009; Larsson et al., 2005; Trabulo
et al., 2015; Van de Poll-Franse, Haak, Coebergh, Janssen-Heijnen, & Lemmens, 2012;
Walker et al., 2013). However, findings based on populations in the Western countries
may not be applicable in the Middle East, and more specifically, in the country of Oman.
Literature on T2DM as an independent risk factor for CRC incidence and mortality in
Oman is scarce. Therefore, I decided to address this knowledge gap with this quantitative
research study on the association between T2DM and CRC risk and survival in Oman.
Purpose of the Study
The purpose of this retrospective quantitative research study was to examine the
association between T2DM and the risk and survival rates of CRC in Oman while
controlling for covariates, such as stage of disease, gender, diet, body mass index (BMI),
physical inactivity, alcohol consumption, smoking, age, and family history in men and
women in the country of Oman. The findings from this study could contribute to a better
understanding of the association between T2DM and CRC risk and survival rates.
Moreover, it could provide the basis for the design of preventive interventions to reduce
CRC burden in the Omani population.
Research Question(s) and Hypotheses
The following research questions and hypotheses guided this study. Statistical
significance was set at 0.05 to be able to accept or reject the null hypotheses.
1.

What is the association between T2DM and the risk of developing CRC in
Oman?
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H01: There is no association between T2DM and CRC risk in Oman.
Ha1: There is an association between T2DM and CRC risk in Oman.
Participants with T2DM will have a higher CRC risk than those without T2DM
2.

What is the association between T2DM and CRC survival in Oman?

H02: There is no association between T2DM and CRC survival rates in Oman.
Ha2: There is an association between T2DM and CRC survival rates in Oman.
Participants with T2DM will have lower survival rates than those without T2DM.
3.

What is the association between T2DM and CRC survival stratified by
gender, age group, tumor location, and cancer stage in Oman?

H03: There are no differences in the association between T2DM and CRC survival
rates by gender, age group, tumor location, and cancer stage, in Oman.
Ha3: There are differences in the association between T2DM and CRC survival
rates by gender, age group, tumor location, and cancer stage, in Oman.
Theoretical Foundation
The ecosocial theory (Krieger, 2001) provided the theoretical base for this
research. The ecosocial theory is used to integrate social and biological knowledge with
dynamic and ecological perspectives to explain the distribution of disease. The four
constructs of the ecosocial theory are embodiment, pathways of embodiment, dynamic
and cumulative interplay between exposure and resistance, and accountability and agency
(Krieger, 2001). People embody the adverse social, physical, and biological exposures
that cause disease, from their conception to death. Practitioners use the ecosocial theory
to analyze the current and changing patterns of population health against the background
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of biological, ecological, and social organizations across multiple levels. By so doing,
epidemiological associations between changing patterns of health and disease states
across time and space can be qualitatively explained (Krieger, 2001).
With regards to the association of T2DM and CRC in the Omani population,
T2DM is associated with CRC through shared risk factors of sedentary lifestyle, obesity,
and insulin resistance. The constructs of embodiment, and the dynamic and cumulative
interplay between exposure and resistance of the ecosocial theory, provided a potential
explanation for this relationship; diabetes and related chronic hyperinsulinemia reduce
circulating levels of IGFBP-1 (thereby reducing its effect on apoptosis), increase
circulating levels of IGF-1 and 3 (these promote cancer cell growth), and enhance the
mutagenic effects of insulin (De Bruijn et al., 2013; Ferroni et al., 2015; Trabulo et al.,
2015). The embodiment of T2DM is viewed not as a disease of endocrine origin, but a
biological process that alters the body’s response to cancer: an alteration that occurs via
the dynamic and cumulative interplay between endocrine processes and gender-related
response to the effect of diet and lifestyle habits (Ferroni et al., 2015). Similarly, the
presence of diabetes may alter the body’s response to carcinogens at different subsites in
the body. In the findings from this study on the association between T2DM and CRC, I
highlighted these subsite- and gender-related differences. Agency and accountability at
different levels would involve individuals, communities, and governments taking
responsibility to counter these biological processes that affect health. This might involve
enacting appropriate policies that make it easier for communities and individuals to adopt
behaviors that promote health.
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Table 1 shows the link between the study variables and the ecosocial theory
constructs that were analyzed in this research, and Figure 1 is a visual representation of
same.
Table 1
Study Variables as They Relate to Ecosocial Theory Constructs
Variable

Related constructs

Comments

Diabetes

Embodiment

Physiological

(incorporation of

processes involving

human biology with

endocrine hormones

individual and societal

that predispose to

lifestyles)

T2DM interact with
diet and lifestyle and
predispose to higher
CRC risk and lower
survival

Gender, diet quality

Cumulative and

BMI, physical

dynamic interplay

activity, Age

between exposure,

family history

susceptibility and
resistance which
differs by sex, stage of

Genetic and
physiological factors
interact with the
lifestyle exposures
and endocrine

disease, diet quality,
BMI, physical activity
level, age and family
history

Note. BMI= Body Mass Index

processes that cause
diabetes to alter
response to CRC
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Figure 1. Study variables as they relate to ecosocial theory constructs
Nature of the Study
This research was quantitative in nature and involved a retrospective, case-control
study to answer Research Question 1 and a retrospective survival analysis of secondary
data for Research Question 2 and 3. Secondary data of CRC patients treated in Sultan
Qaboos University Hospital (SQUH), a tertiary institution that treats more than 50% of
the cancer cases in Oman, were used to address the research questions. For Research
Question 1, a hospital-based, case-control study was used to study the association
between T2DM and CRC risk using data from a previous study on gastrointestinal
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cancers in Oman. The controls for this previous study were patients admitted into the
orthopedic surgery; ear, nose and throat (ENT) and ophthalmology departments of the
same hospital; and treated for acute, nonmalignant conditions that ranged from cataract,
slipped discs, low back pain, simple fractures, sprains, minor traumas, hernia repair, acute
appendicitis, gall bladder stones, and osteoarthritis. For Research Question 2 and 3, a
survival analysis of all CRC cases diagnosed from January 2006 (SQUH fully
transitioned to the use of electronic health records in January2006) to December 2012 in
SQUH was conducted. Identified cases were followed up till December 2016. Those who
were still alive at the end of the follow-up period were censored. Multivariable-adjusted
analyses based on inclusion of covariates, such as stage of disease, diet, BMI, physical
activity, alcohol consumption, smoking status, age, and family history of CRC were
conducted. The case-control study provided insight into the association between T2DM
and incident CRC, while the time-to-event analysis provided insights into the association
between T2DM and CRC survival, in both men and women in Oman
Definitions
Cancer: Cancer is the term used for a collection of more than 100 related diseases
characterized by uncontrollable division of cells in any part of the body. When cancer
cells develop into masses of densely packed abnormal tissue, they are referred to as solid
tumors. Cancers from any part of the body, except for cancers originating from the blood,
can form solid tumors. Cancer is named after the organ or part of the body from which it
originates. However, it has the ability to invade surrounding tissues, and migrate
(metastasize) to other distant parts of the body through the blood or lymphatic system to
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form tumors (National Cancer Institute [NCI], 2015). For example, cancer that originates
in the colon is referred to as colon cancer. However, cells from this primary cancer can
migrate to another organ in the body, such as liver or lung, in which case it is referred to
as metastatic colon cancer. Cancers are categorized according to their cells of origin into
leukemia, lymphoma, myeloma, and sarcomas, carcinoma, neuroendocrine, and germ-cell
cancers (NCI, 2015a).
Cancer registry: A large collection of cancer data related to the diagnosis and
treatment of patients in a given geographic area. Registries can be created for individual
hospitals, regions, states, and at the national level (American Cancer Society, 2016).
Colorectal cancer (CRC): CRC originates in the colon or the rectum. These
cancers can also be named separately as colon or rectal cancer after their site of origin,
but are usually grouped together because they have many features in common. The colon
and rectum make up the large intestine, also referred to as the digestive system, an organ
that is about 5.6 feet (1.80 meters) long with walls consisting of several layers (American
Cancer Society, 2016). The colon makes up the first 5 feet (1.5meters) of the digestive
system while the rectum consists of the remaining 6inches (0.15meters; American Cancer
Society, 2016). CRC starts in the innermost layer (the mucosa) of the wall and can grow
through some or all of the other layers (American Cancer Society, 2016). The cancer cells
can invade the blood vessels or lymph vessels where they can travel to nearby lymph
nodes or to distant parts of the body, such as the liver, brain, or lungs (American Cancer
Society, 2016).
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Diabetes mellitus: Diabetes mellitus (DM) is a metabolic disorder of multiple
etiologies, related to disturbances of carbohydrate, fat, and protein metabolism. It is
caused by defects in insulin secretion and /or insulin action (WHO, 2010). The main hall
mark of DM is hyperglycemia. Uncontrolled, chronic hyperglycemia causes damage to
many of the body's systems, such as the nerves, blood vessels, the kidneys, and the eyes
(WHO, 2010). There are two main types of DM: Type 1 and Type 2 DM. Type 1 DM
(T1DM) develop in childhood and adolescence with patients requiring lifelong insulin
injections (WHO, 2010). Type2 DM (T2DM) is the more common type and represents
about 90% of all diabetic cases worldwide (WHO, 2010). It develops in adulthood and is
related to obesity, lack of physical activity, and unhealthy diets. Fortunately, T2DM may
be reversed by positive lifestyle changes. Other categories of diabetes include gestational
diabetes and rarer types caused by genetic syndromes and acquired processes in diseases,
such as cystic fibrosis and exposure to certain drugs and viruses (WHO, 2010).
Electronic health records: Electronic health records (EHRs) are databases that
contain the results of clinical and administrative encounters between a provider
(physician, nurse, telephone triage nurse, and others) and a patient that occur during
episodes of patient care. (Ambinder, 2005) The purpose of the EHR is to make all of the
information needed for patient care accessible at the point-of-care, for education, and for
practice management. Other functions of EHRs are the reduction of medical errors and
the reduction of redundant paperwork. Electronic links across care settings also facilitates
collaborative and coordinated approaches among caregivers and enhance the tracking and
monitoring of the quality of care activities (Ambinder, 2005).
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Assumptions
The following assumptions were made for this study: First, for the first part of this
study, and to answer Research Question 1, I relied on data from a previous study on
gastrointestinal cancers in Oman. It was assumed that the variables relevant to this study
were available in this dataset. Secondly, to address Research Question 2 to 3, I relied on
the EHRs of patients who were treated and followed up in one of two hospitals that treat
cancer patients in Oman. It was assumed that these patients were representative of CRC
patients in Oman. This assumption was based on the latest Oman national cancer registry
report that indicated that more than 50% of CRC cases diagnosed in 2013 were treated in
SQUH (Oman Cancer Registry Report, 2014). Lastly, it was assumed that the data from
the electronic health records of patients from the hospital were accurate and complete.
These assumptions were critical for obtaining meaningful results.
Scope and Delimitations
The study was delimited to examining the association between T2DM and CRC
risk and survival rates in the Omani Population. The study included adult male and
female citizens and residents of Oman, 18 years of age or older. The study participants
were drawn from secondary data from the EHRs of CRC patients treated in a tertiary
hospital that treats more than 50% of the cancer cases in Oman, and a database for a
previous study on lifestyle risk factors for gastrointestinal cancers in the same tertiary
hospital. Because this hospital handles more than 50% of cancer cases in Oman, the
sample was representative of CRC cases in Oman. The study sample was limited to
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Omani citizens and residents; hence, the study findings may not be generalizable to nonArab populations.
Limitations
Potential limitations to this study were as follows: First, the number of cases in
the dataset may not be enough to provide the required sample size to conduct subgroup
analysis. This could pose a potential threat to the external validity of the result. Secondly,
missing values in the dataset could affect sample size and limit the extent to which
subgroup analyses can be done. Moreover, this was an observational study; therefore,
cause and effect cannot be determined. Selection bias could arise if cases that were not
captured in the original dataset did not exactly match the controls. This could threaten
internal validity. Finally, the study was limited to cases that attended one of two hospitals
that treat cancer cases in Oman; thus, the findings may not be generalized to other nonArab populations.
Significance of the Study
CRC is a global public health problem that generally has a poor prognosis (Kumar
et al., 2015). Of the 900 cancer-related deaths in Oman in 2014, 8.7% were due to CRC
(WHO, 2014). Most of what is known about the association of T2DM and CRC risk and
mortality has been based on studies from Western countries (K.H. Chen et al., 2014;
Dehal et al., 2012; Deng et al., 2012; Erbach et al., 2012; Huang et al., 2011; Jeon et al.,
2013; Jullumstrø et al., 2009; Larsson et al., 2005; Trabulo et al., 2015; Van de PollFranse et al., 2012; Walker et al., 2013). However, findings based on data from Western
countries may not be applicable to populations in the Middle East, such as the Omani
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population; therefore, studying the Omani population is important. Moreover, in Oman,
CRC tended to occur among persons of younger age than is generally found in the West
(Brim et al., 2008; Kumar et al., 2015); yet, the prognostic and risk factors for CRC
among the Omani population are not fully understood. This research was intended to fill
this knowledge gap by focusing on the association between T2DM (a chronic disease that
is also prevalent in the Omani population) and CRC risk and survival rates. The study
findings may inform the design of preventive strategies and policies to address the burden
of CRC in Oman.
Addressing the burden of CRC could mean longer disease-free periods and
overall survival for CRC patients, allowing them longer time to spend with their loved
ones. With longer disease-free periods, CRC patients can return to work and once again
become productive members of their communities, contributing to positive social change.
Positive social change could also be achieved when preventive measures to address the
burden of CRC leads to reduction in the direct and indirect costs associated with CRC
diagnosis and treatment. CRC treatment consists of surgeries, chemotherapy and
radiotherapy, and inpatient and outpatient clinic visits for prolonged periods of time.
Direct costs of such care can range from $1,941 to $48,453 per patient depending on the
stage of the disease at diagnosis (Wong et al., 2012). The direct medical costs for CRC
treatment in the United States in 2011 was $88.7 billion (American Cancer Society,
2015). These figures do not include the indirect costs, such as patient time involved with
receiving medical care and productivity losses among patients and caregivers (Yabroff,
Borowski, & Lipscomb, 2013).
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Summary and Transition
T2DM and CRC are two chronic diseases with significant morbidity and mortality
in Oman (Al Mahrouqi et al., 2011; Al Riyami, 2010; Brim et al., 2008; Muliira et al.,
2016). An understanding of the association between T2DM and CRC risk and survival
may inform appropriate interventions to reduce the burden of CRC. T2DM is a possible
independent risk factor for CRC and prognosis. However, the majority of studies have
been carried on populations from Western countries (K.H. Chen et al., 2014; De Bruijn et
al., 2013; Ferroni et al., 2015; Giovannucci & Michaud, 2007; Jeon et al., 2013; Larsson
et al., 2005; Trabulo et al., 2015; Wolpin et al., 2009). Data on the Arab populations of
the Middle East, such as Oman, are scarce. The aim of this research outlined in this
chapter was to fill this knowledge gap and improve the understanding of this association
in the Omani population. This understanding would be guided by a more detailed review
of the literature in Chapter 2.
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Chapter 2: Literature Review
Cancer is a public health problem worldwide. Despite the progress that has been
made in recent years in the prevention and treatment of many cancers, incidence rates
continue to rise due to an aging global population and an increase in behavioral risk
factors like smoking, obesity, and unhealthy dietary patterns (Lam et al., 2011; Li et al.,
2016). Over 8 million deaths worldwide in 2013 were due to cancer, moving it from the
third leading cause of death in 1990 to the second, behind cardiovascular disease (Global
Burden of Disease Cancer Collaboration, 2015). Among various types of cancers, CRC is
the third most common cancer in the world, and the fourth in terms of cancer-related
deaths, after lung and breast cancers respectively (Global Burden of Disease Cancer
Collaboration, 2015). In Oman, of the 900 cancer-related deaths in 2014, over 78 of them
were due to CRC (WHO, 2014).
In many studies on Western populations, scholars have suggested a link between
T2DM and CRC potentially mediated by factors related to nutrition, chronic
inflammation, and genetic variables (L. Chen et al., 2013). However, despite the
epidemiological transition that has taken place in Oman over the past 4 decades (Al
Shookri et al., 2011), similar studies on risk factors for chronic diseases like T2DM and
CRC are lacking. This is a gap in the literature deserving of research. The purpose of this
research was to contribute to the body of existing evidence by studying the association
between T2DM and CRC risk and survival rates in the Omani population. The findings
from this research may contribute to a better understanding of the prognostic risk factors
of CRC. A better understanding of the link between T2DM and CRC would provide an
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opportunity for prevention strategies aimed at improving the Omani population health.
The social change impact of this may be an increased awareness of the possible risks of
CRC among the Omani people. Furthermore, findings may inform policies and
preventive strategies to reduce behavioral risk factors that fuel the incidence of CRC, thus
contributing to positive social change.
In this chapter, I review the supporting literature and theoretical constructs that
formed the basis for this study. This literature review includes a synthesis and summary
of recent, peer-reviewed literature on T2DM as not only a disease of endocrine origin, but
also a disease that is linked to cultural and societal changes. The impact of T2DM on
multiple organs, its role as a significant contributor to morbidity and mortality from
chronic diseases such as CRC, and the associated economic implications are reviewed. In
addition, the influence of gender, physical inactivity and diet, excessive alcohol, and
tobacco use on the association between T2DM and CRC are also reviewed.
Literature Search Strategy
This literature review related to the research questions in this study and was
limited to articles published between 2000 and 2016. However, older studies related to
the development of the ecosocial theory were also included. Government and
authoritative websites (i.e., the WHO, IDF, NCI, the American Cancer Society, the
International Association for Cancer Research [IACR], the American Institute for Cancer
Research [AICR], the Center for Diseases Prevention and Control [CDC], the World
Cancer research Fund [WCRF], the Canadian Cancer Society, the Oman Cancer Registry,
and the Oman Ministry of Health websites) were searched for current facts related to the

21
major themes of this review. The selected literature was limited to research published in
peer-reviewed journals and on the previously listed websites. Databases that were
searched included Google Scholar, ProQuest central, Thoreau, CINAHL Plus, Academic
Search Complete and Medline, PubMed Central, and Dissertations & Theses at Walden
University. The reference sections of many of the key articles also provided additional
articles. The different themes that were related to the research questions were used to
organize the structure for the literature review. The themes included colorectal cancer,
colorectal cancer incidence, colorectal cancer risk, colorectal cancer risk factors,
colorectal cancer survival, Type 2 diabetes and cancer, Type 2 diabetes and colorectal
cancer, ecological theories, ecosocial theory, diabetes and colorectal cancer survival,
diabetes and colorectal cancer occurrence, cancer and diabetes in Oman, and colorectal
cancer and diabetes in the Arab population. These themes were used as search terms
either individually or in combination to generate the highest number of relevant articles.
The goal of this review was to gain as much insight into these various themes, so
as to design a study that would new generate knowledge. This knowledge could be added
to what is known about the association between T2DM and CRC, as well as fill a gap in
knowledge related to an understanding of the influence of T2DM on CRC risk and
mortality in the Omani population.
Theoretical Foundation
The ecosocial theory (Krieger, 1994) provided the theoretical base for this
research. The possible association between T2DM and CRC (how this association is
affected by diet, physical activity, BMI, and gender) were guided by this theory. The
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ecosocial theory (Krieger, 1994) is one of the newer theoretical frameworks of social
epidemiology with a focus on the integration of social and biological knowledge with
dynamic and ecological perspectives to address the distribution of disease. Building on
the framework of social influences of disease (Smith, 1981), and driven by the need to
explain who and what drives current and changing patterns of population health, the
theory incorporates biological and ecological influences of disease distribution and their
relationship with social factors to analyze disease development among different
demographic groups. The ecosocial theory includes the consideration of social context of
health problems across multiple levels and how these problems contribute to social
inequalities in health to contextualize health promotion strategies (Krieger, 1994).
Epidemiologists and public health practitioners can use the theory to critically consider
their explanations for the persisting and changing patterns of health and how to apply an
integrated approach across time and space when interpreting population health.
The four constructs of the ecosocial theory are embodiment, pathways of
embodiment, dynamic and cumulative interplay between exposure and resistance to
disease, and accountability and agency (Krieger, 2001). These constructs provide a better
understanding of what drives disease distribution at multiple levels in a population.
Krieger (2001) applied the constructs of ecosocial theory to demonstrate how biological
processes interact with social conditions to give rise to biological expressions of social
inequality on issues about discrimination, gender inequality, sexism, human rights and
justice, as well as social exclusion. Krieger argued that epidemiological analyses of
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health outcomes be conceptualized and operationalized in such a way as to capture all the
possible expressions of such outcomes.
Embodiment (Krieger, 2005) is the main construct of the ecosocial theory. This
construct is based on the premise that human beings are both biological and social entities
and carry on their bodies, evidence of the societal and ecological consequences of their
existence. Consequently, embodiment is an explanation for patterns and distribution of
population health even when such explanations do not match or cannot be deduced from
peoples account (Krieger, 2005). For example, BMI, or waist-to hip ratio, are embodied
biological characteristics in individuals and populations that can be measured, and
depending on the health outcome of interest, can provide an explanation for observed
patterns of morbidity and mortality in a population. Embodiment is a process that is
important for understanding the political and power dynamics that influence the choices
people make and their related unconscious health consequences over a period of time
(Krieger, 2005). Embodiment can be used to explain bodily transformations that occur
when people choose to consume fast food in preference to healthier local alternatives as a
symbol of being “Westernized”. Likewise, the increased use of cars and automated
technologies that has replaced people’s ability to be physically active can result in bodily
expressions of obesity. Biological, social, and ecological interactions amongst living
organisms occur over time through pathways that may be physical, biological, and social.
Hence, embodiment allows practitioners to study all aspects of human existence that
impact health: consumption of food, use of language, types and use of recreation, sexual
orientation and practices, use of psychoactive substances, use and experience of violence,
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and experience of emotion (Krieger, 2005). Another example of the process of
embodiment and its pathways is the possible causal relationship between impaired
glucose metabolism and cancer risk.
T2DM typically develops following impaired glucose tolerance and long-term
insulin resistance whereby higher concentrations of endogenous insulin are required for
the normal use of circulating glucose. The resulting chronic hyperinsulinemia triggers a
chain of metabolic responses involving a reduction in the circulating levels of IGFBP-1,
IGF-1, and IGF-3 (Ferroni et al., 2015). Hyperinsulinemia in the presence of lower levels
of circulating IGFBP-1 has been shown to increase CRC risk in prospective observational
studies (Larsson et al., 2005; Trabulo et al., 2015). Furthermore, scholars have suggested
that dysregulation of growth signals involving insulin and IGF-1 promote carcinogenesis
(K.H. Chen et al., 2014; Giovannucci & Michaud, 2007; Jeon et al., 2013; Wolpin et al.,
2009). Similarly, researchers have also demonstrated an association between
hyperglycemia, insulin resistance, and HER2-expressing breast cancers (Ferroni et al.,
2015). Diabetes and related chronic hyperinsulinemia reduce circulating levels of IGFBP1, thereby reducing its effect on apoptosis; increased circulating levels of IGF-1 and 3
promote cancer cell growth and enhance the mutagenic effects of insulin (Ferroni et al.,
2015). From the foregoing, insulin, a well-known regulator of human steroid sex
hormones such as estrogen and aromatase, appears to be a common denominator for both
breast and colorectal cancers via hormonal, inflammatory, and metabolic pathways that
interfere with signal transduction of sex hormones (Ferroni et al., 2015; Vazzana et al.,
2012).
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The embodiment of T2DM is viewed not as a disease of endocrine origin, but a
biological process that alters the body’s response to cancer through the dynamic and
cumulative interaction between endocrine processes and gender-related response to the
effect of diet and lifestyle habits. Similarly, embodiment of T2DM can interact with
genetic and physiological predisposition to alter response to cancer treatment or to cause
variations in tumor characteristics at different subsites in the body. Agency and
accountability at different levels involve individuals, communities, and governments
taking responsibility to counter the biological processes that affect health. Appropriate
policies can be enacted that make it easier for communities and individuals to adopt
behaviors that promote health.
Ecosocial Theory and Related Studies
Using the embodiment construct of the ecosocial theory, Rock (2003) considered
current approaches to defining and preventing the impact of T2DM on population health.
Rock urged practitioners to consider the rising incidence of T2DM worldwide in light of
socioeconomic changes, consumption patterns, and power dynamics that influence how
capacity is built and used. Citing the rising incidence of T2DM among the inhabitants of
Eeyou Istchee, a remote area in the Northwestern subarctic region of Quebec in Canada,
Rock argued that the rise of T2DM in that community corresponded with changes
brought about by modernization that followed the construction of a hydroelectric dam in
2000. Similar to Rock’s idea, Benyshek, Martin, and Johnston (2001) suggested that
economic and social changes contribute to the average rise in blood sugar at any given
time within various populations. Citing as an example the prevalence of T2DM among
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the native Indians of Nebraska in the United States, Benyshek et al. argued that systems
of appropriation, exploitation, and exchange foster a political economy that help shape
social organization and cultural norms that could explain the disproportionate rise in
T2DM among minority groups. Other researchers have also considered how multiple
level factors at the individual, interpersonal, and social and environmental factors
influence adherence to antiretroviral therapy (Phillips, 2011), and how multiple level
socioecological factors (i.e., gender, individual beliefs and attitudes, and social and
environment structures) influence preschool children’s engagement in physical activity
(Mehtälä, Sääkslahti, Inkinen, & Poskiparta, 2014). Although no previous researchers
used the ecosocial theory as a theoretical framework to examine the association between
T2DM and CRC was found in the literature, Rock and Benyshek et al. described social
factors associated with chronic disease that can be applied to the epidemiological and
social changes that have occurred in Oman in the past 4 decades.
Literature Review Related to Key Variables and/or Concepts
Colorectal Cancer
CRC originates in the colon or the rectum. Although both cancers can be named
separately as colon or rectal cancer after their site of origin, they are usually grouped
together because they have many features in common. CRC is a public health problem. It
is the third most common cancer after lung and breast cancers, and the fourth leading
cause of cancer-related deaths in the world after lung, liver, and stomach cancers
respectively worldwide (Global Burden of Disease Cancer Collaboration, 2015). In 2012,
there were an estimated 1.4 million new cases of CRC and almost 694,000 deaths, and it
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is predicted that about 2.4 million cases will be diagnosed annually worldwide by 2035
(Torre et al., 2015). Furthermore, about one in three people diagnosed with CRC die of
the disease within 5 years after diagnosis (American Cancer Society, 2015). In addition to
the human cost of CRC, the tangible and intangible costs of treating CRC are enormous.
The direct medical costs for CRC treatment in the United States in 2011 were $88.7
billion (American Cancer Society, 2015). These figures do not include indirect costs,
such as patient time involved with receiving medical care and productivity losses among
patients and caregivers (Yabroff et al., 2013).
CRC is one of the cancers that are curable if detected early. Most CRCs originate
from adenomatous polyps that progress and mutate slowly to cancer within 10 years to 15
years, giving an ample window for early detection and prompt treatment (CDC, 2017;
Walsh & Terdiman, 2003). The removal of premalignant adenomas and polyps detected
during screening can prevent CRC. On the other hand, the removal of localized cancer
found in the early stages during screening may prevent CRC-related death by the
institution of early treatment (CDC, 2017). The declining rates of CRC incidence and
mortality that has taken place in the United States, Europe, and Australia in the past
decade maybe due to improvements in screening and early detection programs, though it
has been noted that uptake rates remain low (American Cancer Society, 2015; Ouakrim et
al., 2015). According to the American Cancer Society, only 59% of people age 50 or
older, for whom screening is recommended, do receive CRC testing as recommended.
Apart from a small percentage of individuals with certain genetic mutations that
predisposes them to a higher risk of developing CRC, up to 90% of CRC cases are
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nonhereditary and have been linked to modifiable behavioral practices, such as diets high
in red or processed meats, physical inactivity, heavy alcohol consumption, and tobacco
use. These health behaviors are amenable to public health interventions and have the
potential to reduce CRC burden (Spring, Moller, & Coons, 2012). Apart from hereditary
and modifiable life style risk factors of CRC mentioned above, other risk factors include
gender, family health history, and age (MacFarlane & Stover, 2007). The public health
impact of CRC risk is higher in the presence of T2DM (Flood, Strayer, Schairer, &
Schatzkin, 2010; Larsson et al., 2005; Yuhara et al., 2011).
Oman
The Sultanate of Oman is situated in the South Eastern corner of the Arabian
Peninsula and has a total area of 309,500 km2 (WHO, 2016a) It is bordered in the
northwest by the United Arab Emirates, in the west by Saudi Arabia, and in the southwest
by Yemen, and it has an estimated population of 4.49million (WHO, 2016a). Prior to
1970, Oman was largely isolated from the rest of the world and its changing economies
and societies (Smith, 1981). With a population of just over 1 million prior to 1970, there
was only 8 kilometers of paved road and no electricity. Most Omanis lived in rural areas
where villagers worked and contributed to their communities in a system of mutual selfreliance (Smith, 1981). Before 1970, there were only two hospitals in Oman; one was
opened in 1935 by the American Arabian Mission and run by American Missionaries, the
other was established in 1948 and administered by the British Consulate (Al shishtawy,
2010). However, the discovery of crude oil in 1967 and the subsequent wealth that came
with oil revenue y transformed the country.
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From 1970, and with the use of oil revenue, the Omani government embarked on
infrastructural development in all sectors resulting in the transformation of Oman into a
modern society (Smith, 1981). Currently, the population of Oman stands at 4,490,000, of
which 2,428,300 are Omani nationals while the rest are expatriates working in various
occupations in the country (World Population Review, 2016.). There is a network of
roads, purified water, electricity to most homes, and a modern health care system
(Alshoaibi, 2015). Nevertheless, the epidemiological transition that has taken place in
Oman over the past 3 decades has ushered in new challenges. Whereas the government’s
commitment towards good health care planning and provision has led to a decline in
various communicable diseases among the Omanis (Al Shookri et al., 2011), the
emergence of noncommunicable diseases, including cancer, present new challenges (Al
Shookri et al., 2011).
For example, the availability and increased use of technology such as cars and
elevators, and domestic servants has fostered a culture of sedentary lifestyle. Added to
this, is a proliferation of fast food restaurants in response to Oman’s increasing
globalization. As Oman interacts more with the Western world, there has been a shift
away from the traditional Omani diets of grains, spices and fruits, towards a preference
for westernized diets of processed and semi-processed foods, and calorie-dense sugary
drinks. In Oman it is fashionable for whole families to dine at fast foods restaurants as a
way of being “Western-like”. The consequence of this has been that while communicable
diseases have declined, non-communicable diseases such as obesity, cardiovascular
diseases, diabetes and cancers are now on the rise in Oman (Al Nohair, 2014).

30
Although incidence rates for CRC are still higher in more developed countries
like Australia, countries in western Europe, North America, and high-income AsiaPacific countries due to dietary and lifestyle habits of high consumption of red and
processed meat, high alcohol consumption and tobacco use (Global Burden of Disease
Cancer Collaboration, 2015; Hakulinen, 2007;), Middle Eastern countries such as Oman
are witnessing a rising trend (Al Mahrouqi et al., 2011; Brim et al., 2008; Muliira et al.,
2016). In addition to the observation that the Omani dietary patterns are being
increasingly westernized, there are also distinct variations in Oman cooking practices
from that of the West which may predispose to cancer (Azeem et al., 2015). For example,
salt- preserved fish is eaten in certain parts of Oman; preserved foods with high sodium
content have been linked with CRC (Azeem et al., 2015).
CRC is the most commonly diagnosed cancer among Omani men, and the third
most common in Omani women with incidence rates of 10.2 and 8.5 per 100,000 cases
for men and women respectively (WHO, 2014). In 2013, CRC accounted for 9.0% of all
deaths in adult Omani males and 8.3% in females (WHO, 2014). Furthermore, while
there has been marked reduction in incidence and death rates across developed countries
due to improved screening services, early detection, and specialized care (American
cancer Society, 2016), screening and early detection services for CRC are lacking in
Oman. As a result of this, many CRC cases are detected in the late stages where the only
option of treatment is palliative. Moreover, observational studies have indicated that CRC
occurred among Omanis of younger age than is found in the West (Ashktorab et al.,
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2008; Brim et al., 2008). Despite these observations, the prognostic factors for CRC have
not been studied in the Omani population. This research study attempted to fill this gap.
Type 2 Diabetes (T2DM)
Diabetes mellitus (DM) is a metabolic disorder of multiple etiologies related to
disturbances of carbohydrate, fat, and protein metabolism. It is caused by defects in
insulin secretion, and /or insulin action (WHO, 2010). The main hall mark of DM is
hyperglycemia. Uncontrolled, chronic hyperglycemia causes serious damage to many of
the body's systems, such as the nerves, blood vessels, the kidneys, and the eyes (WHO,
2010). The adverse effects of hyperglycemia on the body systems is responsible for the
macro- and microvascular complications of DM, such as cardiovascular diseases, lower
limb amputations, diabetic nephropathy and neuropathy, kidney failure, and blindness
(IDF, 2015; WHO, 2010). There are two main types of DM: T1DM and T2DM. T1DM
usually develops in childhood and adolescence with patients requiring lifelong insulin
injections. T2DM is the more common type and represents about 90% of all diabetic
cases worldwide. It develops in adulthood and has increased alongside cultural and
societal changes (IDF, 2015). It is related to obesity, lack of physical activity, and
unhealthy diets (WHO, 2010). T2DM was the focus of this research.
The prevalence of T2DM is increasing worldwide. According to the IDF (2015),
the threat of T2DM is one of the biggest global health emergencies of the 21st century.
The current estimate of adults with T2DM stands at 415 million. An additional 318
million people have impaired glucose tolerance which puts them at high risk of
developing T2DM in the future (IDF, 2015). Up to 12% of global health expenditure is
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dedicated to the treatment of T2DM and related complications. The greatest barrier to
tackling the scourge of this disease is the lack of awareness of its social and economic
impact in many countries (IDF, 2015). The rising prevalence of T2DM worldwide is
thought to be due to a combination of factors such as an ageing population, improved
detection of undiagnosed T2DM, an increase in the number of people who are overweight
or obese, and decreasing population physical activity levels (Smith & Hamer, 2014).
The Cooperation Council for the Arab States of the Gulf comprises of six
countries with similar culture (Saudi Arabia, Kuwait, the United Arab Emirates, Qatar,
Bahrain, and Oman). According to the IDF (2015), these countries exhibit some of the
highest rates of T2DM in the world, attributed to their recent and rapid socioeconomic
development and epidemiological transition. The prevalence of T2DM in Oman is also
on the rise. From 1991 to 2000, the prevalence of T2DM rose from 8.3% to 11.6 % (Al
Shookri et al., 2011). Oman has an anticipated 13.4-14.9% prevalence of diabetes for
2010-2030 (IDF, 2015). About 30% of the Omani population is overweight, 20% are
obese and 12% have T2DM (Al Riyami, 2010). These findings, coupled with the
observation that CRC occurred in Omanis of younger age than found in Western
populations suggests there is a gap in the literature. It also suggests that research such as
this study on the association between T2DM with CRC in the Omani population might be
useful for healthcare planning and interventions.
T2DM and CRC Risk
Numerous epidemiological studies have reported a positive association between
T2DM and CRC (L. Chen et al., 2013; De Bruijn et al., 2013; Deng et al., 2012; Erbach
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et al., 2012; He et al., 2010; Jarvandi, Davidson, & Schootman, 2013; Krämer et al.,
2012; Larsson et al., 2005; Levi, Pasche, Lucchini, & La Vecchia, 2002; Sandhu, Luben,
& Khaw, 2001; Seow, Yuan, Koh, Lee, & Yu, 2006; Trabulo et al., 2015; Yuhara et al.,
2011). However, findings have been inconsistent with regards to CRC site- and genderspecific risk. Whereas some studies with large sample sizes, indicated that overall, there
was a significant association between T2DM and CRC (Flood et al., 2010; Jarvandi et al.,
2013), other studies found an association between T2DM and proximal but not distal
colon (Jarvandi et al., 2013). Yet other studies showed that this association was
significant for distal colon but not for rectum (Yuhara et al., 2011). These inconsistencies
may be attributed in part to differences in baseline characteristics, methodological
designs or CRC heterogeneity (L. Chen et al., 2013), or insufficient power due to small
sample sizes during subgroup analyses (Jeon et al., 2013).
For example, Sandhu et al. (2001) examined the relationship between T2DM,
family history and risk of prevalent CRC in a European population. The authors used a
cross sectional sample of 29,343 participants from the East Anglian component of the
European Prospective Investigation into cancer (EPIC-Norfolk) study. They found that
for both males and females, those who had T2DM had almost three-fold increased risk of
CRC compared to those without T2DM. Similar results were reported by Levi et al.
(2002), and Seow et al., (2006). Levi et al., (2002) conducted a case control study on a
sample of 836 Swiss men and women. These authors found that overall; participants with
T2DM had almost a two-fold risk of CRC compared to those without a history of T2DM.
When stratified by gender, this risk was slightly higher in women compared to men. In
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another study, Seow et al., (2006), examined the association between a history of T2DM
and CRC among a sample of 63257 ethnic Chinese population of Singapore. In this
prospective study, Seow and colleagues found a 50% higher risk of CRC in diabetics
compared to non-diabetics.
With regards to gender- specific differences, some studies have found an
increased risk of CRC in women with T2DM but not in men (Chodick et al., 2010; Flood
et al., 2010; Levi et al., 2002), while others found increased risk in men but not in women
(Campbell et al., 2010; L.Chen et al., 2013). L.Chen et al., (2013) reported an overall
higher incidence of CRC in diabetic subjects compared to non-diabetic controls.
However, an increased risk of rectal cancer was observed in diabetic men but not in
women. Similarly, a subgroup analysis conducted by Seow et al., (2006) above, showed
that diabetic men had a slightly higher but, non-significant risk of CRC than diabetic
women (RR= 1.5 vs 1.4, p =.64). Krämer et al., (2012) found that T2DM was associated
with a moderately increased risk of CRC in both men and women though with a slightly
higher risk in women. Their study was a metaanalysis of twenty-nine gender-related
studies on the association between T2DM and CRC incidence. This metaanalysis
included cohort and case control studies conducted in the Australia, USA, Europe, Japan,
Korea, China, Israel and Iran. The slightly higher risk observed in the female gender was
attributed to gender-specific differences related to the estrogen pathway and the
estrogenic nature of CRC; a finding that was also supported by the study done by Foster,
(2013). Krämer and colleagues called for cancer control and prevention strategies that
included efforts to address the rise in T2DM.
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Despite the numerous individual studies (Campbell et al., 2010; Chodick et al.,
2010; He et al., 2010; L. Chen et al., 2013; Levi et al., 2002; Sandhu et al., 2001; Seow et
al., 2006), and metaanalysis (Krämer et al., 2012; Larsson et al., 2005; Yuhara et al.,
2011) that have reported an association between T2DM and CRC incidence, the strength
of this association in terms of site- and gender –specific risk remains inconclusive. The
findings from this research could make a contribution towards a better understanding of
this association. The findings may aid the formulation of supportive policies aimed at
improving CRC prevention strategies in the Omani population.
T2DM and CRC Mortality
The effect of T2DM on CRC prognosis has been inconsistent with studies
reporting conflicting results (Huang et al., 2011; Jullumstrø et al., 2009; Larsson et al.,
2005; Van de Poll-Franse et al., 2012; Dehal et al., 2012). While some studies have
reported no association between T2DM and overall survival in CRC patients (Ahmadi,
Mobasheri, Hashemi-Nazari, Baradaran, & Choobini, 2014; Morrison et al., 2011; Noh,
Hwang, Choi, & Lee, 2010), other researchers (Huang et al., 2011; K.H. Chen et al.,
2014; Luo et al., 2014.) showed that T2DM is associated with higher CRC mortality.
Still in other studies, as in the study by Jeon et al. (2013), a positive association was
found between T2DM and colon specific survival but, not with rectal cancer. On the
other hand, Van de Poll-Franse et al. (2012), reported poor survival in rectal cancer
patients with T2DM and a non- significant association between T2DM and colon cancer
survival. The inconsistencies in epidemiological studies, coupled with the scarcity of
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similar studies on the Arab population of the Middle East such as the Omani population,
presented a gap in the literature that this research attempted to fill.
Gross et al. (2006), used data from the Surveillance Epidemiology and End
Results (SEER) database to examine the effect of comorbid DM, chronic obstructive
pulmonary disease (COPD), and congestive heart failure (CHF) on the survival of older
persons diagnosed with stage 1-3 CRC, between 1993 and 1999 in the United States. The
authors looked at the effect of each comorbid condition separately, and in combination
with others, on the risk of mortality across all stages of CRC. After a median followup
period of 4.6 years, the results showed that those with no comorbid condition had a fiveyear survival rate of 78.3% for stage 1 disease. However, the five-year survival rates
decreased to 71% with comorbid DM, 65% for COPD, and 55% for CHF respectively, in
patients with stage 1 disease. Further analysis with combinations of comorbid conditions,
showed that patients with two or more comorbid conditions had a much lower 5- year
survival rate; 49.6% for stage 1 disease. Survival rates further decreased to 42.3% and
27.7% for stages 2 and 3 disease respectively. These results suggest that the presence of
multiple morbid conditions in older persons with CRC substantially and negatively
impacted prognosis. Gross and colleagues concluded that a greater understanding of the
effect of multiple chronic conditions on CRC outcomes in older persons will guide
clinical decisions in elderly persons with CRC.
Luo et al. (2014), obtained similar results when they examined the influence of
preexisting diabetes on CRC prognosis in another cohort of elderly patients aged 67 years
and above. Their sample consisted of CRC cases diagnosed between 2003 and 2009 from
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the SEER and Medicare database. These researchers found that patients with T2DM had
a 20% higher risk of mortality than those without T2DM for all stages of CRC. This risk
was 50% higher in patients who had T2DM with cardiovascular disease (CVD), and
COPD complications. When the data were analyzed in terms of site-specific mortality, a
significant association was observed only in colon cancer cases that had both T2DM and
CVD. Mortality in rectal cancer cases was non-significant (Luo et al., 2014). The authors
concluded that pre-existing T2DM increased the risk of all-cause mortality in CRC
patients but this risk maybe due to the increased risk from other co-morbid conditions
such as cardiovascular complications.
Suggestions that the increased CRC risk in patients with T2DM may be due to coexisting comorbid conditions have been advanced by other authors (Larsson et al., 2005;
Jeon et al., 2013; Ahmadi et al., 2014). However, in some other studies (Lam et al., 2011;
Yuhara et al., 2011), the association between T2DM and CRC mortality remained
positive even after controlling for these potential confounding variables, suggesting that
other specific DM mechanisms maybe responsible for this association. According to
Onitilo et al. (2012a), T2DM in cancer patients is associated with negative outcomes
through complex multifactorial pathways. They argued that none of the many plausible
mechanisms that have been advanced to explain this association has yet been
substantiated. These researchers suggested that this association be kept in mind during
treatment decision making and, in the planning of screening and prevention programs.
One limitation of the study by Gross et al., and Luo et al above, is that the study
samples were limited to elderly patients aged 67years and above and may not be
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generalized. This study on the association between T2DM and CRC risk and mortality in
Oman attempted to overcome this limitation by drawing a sample from the population of
all adults, age 18 years and above, diagnosed with CRC in SQUH within the study
period. Again, given that advanced age is an independent risk factor for mortality, the
findings of the Gross et al. and Luo et al. studies may be biased towards people of
younger age. Moreover, comorbid conditions that occur as a result of the natural aging
process may contribute to the observed effect on CRC mortality (Sjödahl, Rosell, &
Starkhammar, 2013). Hence, these comorbid conditions may have confounded the effect
of T2DM on CRC mortality in these two studies. In one study that used a more
representative sample than the study of Gross et al. and Luo et al., T2DM was associated
with poor survival from colon but not from rectal cancer (Jeon et al., 2013). The authors
concluded that the potential mechanisms by which DM affects the different subsites in
CRC differs and warrants further studies.
De Bruijn et al., (2013), examined the association between T2DM and cancer
incidence, and cancer-specific mortality in patients with breast and colorectal cancer in a
large sample of over 1 million individuals with T2DM. This study was a metaanalysis of
20 studies that included one randomized controlled trial, 17 prospective cohort studies,
and 2 systematic cohort reviews. T2DM was associated with a 30% increased risk of
mortality from CRC even after adjusting for potential confounders. One limitation of this
metaanalysis was that it included some studies that did not differentiate between the two
types of DM. Also, the mechanism by which the two types of DM are associated with
cancer development may differ (Shu et al., 2010). Secondly, the authors did not control
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for the use of antidiabetic medications such as metformin that has been demonstrated to
have a protective effect on breast and colon cancer (Lee et al., 2012), and insulin which
has been implicated in carcinogenesis (Chang, Lin, Wu, Lai, & Chuang, 2012; Dehal et
al., 2012; Forssas et al., 2013; K.H. Chen et al., 2014). For example, Dehal et al. (2012),
conducted a study to examined the association between T2DM) and survival among
patients with CRC, stratified by sex, insulin treatment, and durations of T2DM and
insulin use. They used a sample of 2,278 men and women diagnosed with non-metastatic
colon or rectal cancer between 1992 and 2007 in the Cancer Prevention Study-II
Nutrition Cohort. Compared with CRC patients without T2DM, those with T2DM had a
more than 50% risk of all-cause mortality and almost 30% risk of CRC-specific mortality
in both men and women. Furthermore, insulin use was independently associated with
almost 70% risk of death from all causes in those with T2DM compared with those
without. Similar effects of insulin on cancer mortality were observed in the study by
K.H.Chen et al., (2014) who reported a more than 50% higher risk of CRC mortality in
T2DM patients on insulin. Likewise, Forssas et al. (2013), reported a relative overall
excess cancer mortality in diabetic patients, especially in women treated with insulin
compared to non-insulin treated participants.
Other pathophysiological mechanisms by which T2DM increases the risk of CRC
mortality in diabetic patients have been advanced by numerous studies. These
mechanisms include hyperinsulinemia, hyperglycemia (the hallmark of DM) and
oxidative stress (Díaz-Algorri et al., 2015; Jeon et al., 2013; Ferroni et al., 2015; Larsson
et al., 2005; Onitilo et al., 2012b). Other pathways include insulin resistance and obesity-
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related processes such as chronic inflammatory conditions and changes in adipokines
(Bardou, Barkun, & Martel, 2013; Jonasson, Cederholm, & Gudbjornsdottir, 2014;
Morrison et al., 2011; Noh et al., 2010; Onitilo et al., 2012b). Delayed colon content
transit time and hormonal mechanisms involving estrogen, insulin and insulin-like
growth factor-1 also play a role (Bardou et al., 2013; Lam et al., 2011; Lauby-Secretan et
al., 2016; Shi et al., 2015; Popescu-Vâlceanu et al., 2015).
The adverse effect of colon content transient time in T2DM patients is related to
autonomic neuropathy, an often unrecognized side effect of T2DM that causes colonic
dysfunction such as constipation and elevated fecal bile acid secretion (Huang et al.,
2011; Prawitt, Caron, & Staels, 2011). Constipation causes a delay in bowel content
transit time thereby exposing the colonic mucosa to toxins and carcinogens. Moreover,
elevated fecal bile acid concentration induces DNA damage and disrupts the normal
metabolic functions of bile acid such as the regulation of lipid, glucose and energy
metabolism (Ahmadi et al., 2014; Huang et al., 2011; Popescu-Vâlceanu et al., 2015). In
addition to the above mentioned mechanisms, lifestyle-related factors common to both
diseases, such as unhealthy diet, physical inactivity, obesity, smoking and alcohol
consumption may modify the association between T2DM and CRC.
Lifestyle- related factors influencing T2DM and CRC
Recent epidemiological updates from the WHO, IACR, the AICR, WCRF, and
the CDC, have established that diet, obesity, physical inactivity and other lifestyle factors
such as tobacco and excess alcohol use contribute significantly to CRC and outcomes.
The combined impact of these factors on CRC, in the form of a healthy life style index
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score, has also been examined by some studies (Aleksandrova et al., 2014; Cavicchia et
al., 2013; Kirkegaard et al., 2010; Odegaard, Koh, & Yuan, 2013; Tabung ,Steck, Burch
et al., 2015). In these studies, a higher healthy life style index (HLI) score was associated
with a lower risk of CRC by as much as 20-60%. However, in some of the studies
(Kirkegaard et al., 2010; Odegaard et al., 2013; Cavicchia et al., 2013), this association
was only significant for the colon subsite. These same risk factors have been implicated
in T2DM and, may in some way, interfere with the association between T2DM and CRC
(Ezzati, & Riboli, 2013; He et al., 2010; Onitilo et al., 2012b).
Diet
Major health organizations such as the WCRF, the AICR, the American Cancer
Society, the American Diabetic Association, and the Canadian Diabetic Association, have
emphasized the important role that diet plays in the risk of CRC and T2DM.
Consequently, they have made recommendations on the type, quantity and quality of diet
that is essential to reduce the burden of both diseases. According to these organizations,
diets rich in whole grains, fruits, vegetables, monounsaturated fats, dietary fibers and nuts
are considered healthy and should be consumed in preference to processed and energyrich foods, red meat and sugar sweetened beverages. These recommendations are based
on scientific evidence which showed that diets that consist of fibers, whole grains, fruits,
vegetables and monounsaturated fats decrease inflammation and improve insulin
sensitivity. Moreover, such diets are associated with weight loss which in turn improves
blood sugar control (Onitilo et al., 2012b).
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In line with the recommendations of these large health organizations, many
epidemiologic studies have also demonstrated a positive association between diet and risk
and outcomes of T2DM and CRC. For example, Jarvandi et al., (2013), examined the role
of diet quality on the association between T2DM and CRC in a large prospective study of
484,020 individuals, aged 50–71 years. The sample was drawn from the prospective
National Institutes of Health-AARP Diet and Health Study. During a followup period of
about 9.2 years, 7,598 new cases of CRC were identified. After controlling for nondietary confounders, the result showed that both history of T2DM and poor diet were
associated with increased risk of CRC. Patients with T2DM had a 27% increased risk of
CRC compared to nondiabetics. When adjusted for diet quality, this risk was slightly
attenuated, but remained significant, indicating that diet and T2DM independently and
additively increased the risk of CRC. The Omani diet has moved from the traditional
diets grains and dates towards more westernized diet with the advent of crude oil wealth
and globalization. However, how this diet shift has affected CRC risk over the years in
the Omani population remains unknown. Therefore, this research attempted to fill this
knowledge gap.
Overweight and Obesity
Overweight and obesity are the abnormal or excessive accumulation of body fat
that results from an imbalance between energy intake in food and drinks, and energy
expenditure. In 2014, about 640 million adults were obese (WHO, 2015). According to a
WHO report, the estimated age-standardized prevalence of obesity in 2014 was 10.8%
among men and 14.9% among women (WHO, 2015). In 2013, an estimated 4.5 million
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deaths worldwide were caused by overweight- and obesity- related complications (WHO,
2015). Major cancer research organizations have stated that overweight and obesity
increase the risk of many chronic diseases including diabetes and cancer. Recent AICR
reports and updates indicate that excess body fat is a risk factor for CRC and ten other
different cancers and as much as 20% of many common cancers are caused by excess
body fat (AICR, 2016). According to the IACR, the obesity-related cancer burden is
about 9% of the cancer burden among women in North America, Europe, and the Middle
East (Lauby-Secretan et al., 2016).
In a recent exercise to reassess the preventive effects of weight control on cancer
risk, the IACR working group reviewed evidence from more than 1000 observational
studies including metaanalyses. They concluded that there was sufficient evidence that
BMI which is a marker of obesity was significantly associated with the risk of colon and
rectal cancer (Lauby-Secretan et al., 2016). This association followed a positive doseresponse pattern and was consistent across gender and geographic regions (LaubySecretan et al., 2016). Similar findings were reported by Ma et al., (2013) in their metaanalysis involving a population of more than 10 million from 24 different prospective
studies across Asia, Australia, Europe and North America. According to the authors, the
causal link between obesity and CRC is mediated through metabolic and endocrine
abnormalities, especially through alterations in sex hormone metabolism, insulin and IGF
signaling, and oxidative stress arising from release of adipokines, inflammatory
cytokines, and reactive oxygen and nitrogen species (Ma et al., 2013). Bardou et al.
(2013), also observed a consistent association between obesity and CRC risk and
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mortality in men, but less so in women. Their study was a pooled analysis of five
metaanalysis involving more than 10,000 subjects (Bardou et al., 2013). Similar to Ma et
al., (2013), Bardou and colleagues also pointed to metabolic and endocrine abnormalities
as responsible for the association between obesity and CRC. A few studies have however
yielded contrary results (Katerina Neumann, Mahmud, Metcalfe, & Hochman, 2015;
Morrison et al., 2011). In the study by Morrison et al, no association was found between
high BMI, T2DM and CRC outcomes. Similarly, Katerina Neumann and colleagues
found no significant association between obesity and the odds of higher grade or stage of
CRC whereas, in the study by Jarvandi et al. (2013), obesity was associated with an
increased risk of CRC in men, but not in women. Going by this hypothesis, obesity,
which is a common comorbidity of T2DM, could confound the association between
T2DM and CRC.
Obesity prevalence is on the rise in Oman, more so in females than in males. Al
Riyami (2010) reported that 20% of the Omani population is obese. In 2014, the figures
rose to 25% (Al Nohair, 2014). More recent WHO estimates indicate that 27.2% adult
Omani males and 37.7% females are obese (WHO, 2015). Given that obesity is a risk
factor for many chronic diseases including T2DM and cancers, it is no surprise that
T2DM also appears to be prevalent in the Omani population. The WHO estimates stand
at 17.2% T2DM for males and 15.1%, for females (WHO, 2015). Moreover, T2DM
accounted for 10% of total deaths in Oman among both genders within the same period
(WHO, 2015). It is important to note that of all the studies about the association between
obesity, T2DM and CRC (Bardou et al., 2013; Cong et al., 2014; Karahalios, English, &
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Simpson, 2015; Ma et al., 2013; Tilg, & Moschen, 2014), none was conducted in the
Omani population. This gap in the literature could be filled by this research to fill.
Physical inactivity
The role of physical inactivity as a risk factor for many cancers has been
documented by epidemiological studies. With regards to CRC risk, physical activity was
inversely associated with CRC risk in a metaanalysis of cohort and case control studies
(Johnson et al., 2013). Other studies have also suggested that physical activity conferred
survival benefits in CRC and breast cancer cases (Boyle, Fritschi, Heyworth, & Bull,
2011; Li et al., 2016; Kuiper et al., 2012). This observed protective effect of physical
activity on CRC mortality is thought to be related to a number of physiological
mechanisms involving the IGF pathway, improved insulin sensitivity, lower BMI, lower
sex hormones, reduced adiposity, insulin and c-peptide levels, and inflammation (Sax et
al., 2014; L. Chen et al., 2013). Higher levels of physical activity have also been found to
reduce risk of T2DM by similar mechanisms (Onitilo et al., 2012b).
Researchers also examined the effects of physical inactivity on the risk of T2DM
(Smith, & Hamer, 2014; Grøntved & Hu, 2011). Smith and Hamer (2014) examined the
association between television viewing time and risk of incident T2DM in a sample of
adults older than 65 years of age in England. Their result showed that participants who
were inactive and had high television viewing time at baseline were almost twice more
likely to have T2DM at 2-year followup than those who were active with low television
viewing time. The result also showed that those who had high television viewing time but
were physically active were not at risk. The authors concluded that physical inactivity
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was critical to the incidence of T2DM and suggested that interventions that focus on
increasing physical activity have the potential to reduce T2DM in the elderly. However,
this study sample was limited to adults who are older than 65years and may not be
generalized. Grøntved and Hu (2011), conducted a metaanalysis of 8 prospective cohort
studies published between 1970 and 2011 to examine the association between television
viewing time and T2DM, fatal and nonfatal cardiovascular disease, and all-cause
mortality. A total of 175 938 individuals with over 1.1 million person-years of followup
were involved in this study. Four of the included studies reported results on the effect of
television viewing on T2DM. The results showed that there was a linear increase in the
risk of T2DM with the number of hours per day of TV viewing. Although this study was
prospective in nature and included large sample sizes and long followup periods, the
study population included only studies done in Europe, Australia and North America and,
may not be applicable to Arab populations in the Middle East whose bodily response and
way of life are distinct from that of the West (Azeem et al., 2015). This study which
sought to examine the association between T2DM and CRC in the Omani population
could likely fill this gap in the literature.
Alcohol Consumption and Tobacco Use
Published studies on the association between alcohol consumption, tobacco use,
and CRC risk and mortality have suggested that tobacco use increases risk of CRC
through long term exposure to polycyclic aromatic hydrocarbons and carcinogenic
compounds found in cigarette smoke (Slattery et al., 2004; McCleary et al., 2010). On the
other hand, the association between alcohol use and CRC related to the formation of free
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radicals from the alcohol metabolite, acetaldehyde (Rueda et al., 2012). Moreover,
excessive alcohol consumption; and tobacco smoking induces inflammation and DNA
instability in the gastrointestinal tract which, in turn, promotes carcinogenesis (Wilson, &
George, 2014). Some studies have also shown that both tobacco use and excessive
alcohol consumption predispose to the development of chronic inflammatory conditions
which eventually progresses to CRC (Giovannucci & Michaud, 2007; Otani et al., 2006;
Wilson, & George, 2014).Moreover, a dose-and time- dependent association between
tobacco use, and CRC incidence and outcome, was consistent in most of the studies.
In the study by Rueda et al. (2012), those who smoked were 19% more likely to
develop CRC than never smokers, an effect that increased in magnitude with increasing
number of packs smoked, and the number of years of smoking. As with tobacco use,
Rueda et al. also found that the association between alcohol and CRC risk appeared to be
dose-dependent, especially in males Moreover, they found that current use of alcohol
and/ or tobacco was associated with early onset CRC, prompting them to call for an
updated modified screening criteria for CRC, which would include males and females, 40
year of age.
Similar results were reported by Phipps et al. (2013), in randomized phase 3
adjuvant chemotherapy trials among patients with stage III colon cancer. These
researchers found that, compared to never smokers, ever smokers were significantly at a
higher risk of death. This association was slightly stronger for current than former
smokers. They also found that duration and number of cigarettes smoked was associated
with poorer outcome. A few studies found that risk differed by gender (Boyle, Fritschi,
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Platell, & Heyworth, 2013), and geographical location (Hou et al., 2014). Hou and
colleagues evaluated the association between smoking and CRC risk among a large
Chinese population and found that in addition to the dose-response association with
smoking and alcohol consumption, greater CRC risk was found in rural than in Urban
men. In the study by Boyle et al. (2013), female current smokers, but not males, had
poorer survival compared to never smokers. On the contrary, Phipps et al. found no
significant association between smoking and CRC survival among women. A few other
results found no significant association between cigarette smoking and CRC outcomes
(McCleary et al., 2010; Nordenvall, Nilsson, Ye, Andersson, & Nyrén, 2013), which
according to Phipps et al., might be related to tumor characteristics or, differences in
study protocols. Phipps and colleagues stressed the importance of patient and tumor
characteristics when evaluating the associations between risk factors and CRC prognosis
Prevalence data on alcohol consumption in the Arab countries of the Middle are
scarce due to religious and sociocultural restrictions on alcohol use. The few available
prevalence studies were conducted among patients in psychiatric centers or by a review
of hospital notes of patients admitted into hospitals for different reasons (Zaidan, Dorvlo,
Viernes, Al-Suleimani, & Al-Adawi, 2007; Al Marri & Oei, 2009). One such study
(Zaidan et al., 2007), examined the severity of harmful and hazardous drinking in Oman
in nonpsychotic Omani nationals that sought treatment in a psychiatric hospital for
substance abuse. The authors found that 66% of the 56 patients interviewed consumed
alcoholic beverages regularly. More than half of these patients admitted they consumed
alcohol on a daily basis. In a study by Al Riyami and Afifi (2004), the crude prevalence
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of current smoking among Omanis was 7%. In this study, the highest prevalence of
current smokers occurred in the 40-49 age groups. These researchers called for health
awareness strategies aimed at adolescents, and government policies to reduce smoking.
Till date, no previous study has reported on the effect of alcohol consumption and
smoking on the association between T2DM and CRC in the Omani population. This gap
in the literature was what this proposed research attempted to fill.
Gender
Epidemiological evidence suggests that men are at a slightly higher risk for
T2DM and cancers than females. Generally, men have a higher lifetime probability of
being diagnosed with an invasive cancer (45%) compared to 38% in women (Siegel,
Naishadham, & Jemal, 2012). Similarly, 11.8% of all men over the age of 20 years have a
higher risk of T2DM than 10.8% of women of the same age (CDC, 2011). Study results
on the association between T2DM and CRC by gender have been somewhat inconsistent
(Campbell et al., 2010; He et al., 2010; Krämer et al., 2012). The study by Campbell et al.
(2010), involved a sample of 73,312 men and 81,663 women, of which 227 men, and 108
women had T2DM respectively. The researchers found a 24% higher risk of CRC in men
with T2DM compared to those without T2DM. However, in women, there was no
difference in risk of CRC in those with T2DM compared to those without. The
researchers attributed their finding to sex differences in the use of metformin, and better
glucose control in women compared to men. Metformin is more frequently prescribed for
women with T2DM, and has been associated with lower risk of CRC (Campbell et al.,
2010). Contrary to these findings, He et al., (2010), reported that compared to
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nondiabetics, women with T2DM had a significantly greater risk of CRC (28%) than
diabetic men (18%). However, in a metaanalysis by Krämer et al., (2012), researchers
found that compared to those without diabetes, a significant association between T2DM
and CRC was similar for men and women with T2DM. This metaanalysis included 29
cohort and case-control studies conducted in Australia, China, Europe, Iran, Israel, Japan,
Korea, and the United States. None of the studies was from the Middle East or Oman for
that matter. In this research study, I attempted to fill this literature gap.
Age and family health history
Age and hereditary are nonmodifiable risk factors for many chronic diseases
(WHO, 2015). In addition to the natural loss of function of important organs that occurs
with aging, the accumulation of modifiable risk factors that occurs throughout the life
course predisposes older people to higher risk of chronic diseases including cancers
(WHO, 2015). Similarly, the IDF stated that age and a family history of diabetes are
among the several risk factors that are associated with T2DM (IDF, 2015). Consequently,
accounting for age and family history in the association between T2DM and CRC would
aid in the interpretation of findings from this study.
Researchers have recommended that collection of an up to date family history is
necessary because it is a strong predictor of an individual’s risk of common complex
diseases such as diabetes and cancer (Hinton, 2008; Powell et al., 2013). Furthermore, a
person’s family health history provides opportunity for disease risk assessment, and the
implementation of prevention strategies against common but complex diseases in at- risk
individuals (Hinton, 2008; Powell et al., 2013). For example, the risk of breast cancer is
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about 1.8 times higher in women with a history of breast cancer in a first-degree relative.
This risk becomes three times higher if two of her first-degree relatives have cancer
(Hinton, 2008; Powell et al., 2013). Similarly, a family history of colon cancer at younger
age in a first-degree relative is a criterion for beginning colonoscopy screenings before
the age 50 years (Powell et al., 2013), and the referral for genetic testing of family
members (Hinton, 2008).
Johnson et al. (2013), conducted a metaanalysis of 12 non-screening risk factors
of CRC. Their aim was to develop a risk assessment model that would be useful to
clinicians and the public for predicting the risk of developing CRC in different
individuals. Among the 12 non-screening risk factors that were analyzed, a family history
of CRC in a first degree relative and presence of inflammatory bowel disease, were
associated with a higher risk of CRC than other factors such as increased BMI and red
meat consumption. The authors found that compared to those without a family history of
CRC, individuals with a family history of CRC in a first-degree relative were almost 2
times more likely to develop CRC. Some researchers have reported that CRC tended to
occur in Omanis of younger age than found elsewhere (Brim et al., 2008; Kumar et al.,
2015). Moreover, marriage between relatives is common in Oman on the basis of the
Omani culture. This could be the genetic basis of propagation of CRC in some Omani
families yet; there are no studies on the prognostic effect of age and family history of
CRC on the association between T2DM and CRC in Oman. This research could make a
contribution to the literature in this area.
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Summary and Conclusions
The literature review presented in this chapter summarized data on the association
between T2DM and CRC risk and survival. Potential confounders, based on existing
literature were also reviewed. While findings point to an association between T2DM and
CRC, some inconsistencies related to tumor subsite, gender differences, sample size, and
study design warrant further studies. Reviewed evidence is in favor of an association
between T2DM and CRC risk and mortality. However, inconsistencies were apparent
regarding the strength of this association. An apparent gap in this literature review was
that none of the studies in the literature were carried out on the Arab populations of the
Middle East. Thus, the aim of this research was to address this knowledge gap by
assessing the association between T2DM and, CRC risk and survival among the Omani
population. The influence of diet, obesity, physical inactivity, alcohol consumption,
tobacco use, age, and family history of CRC on this association was examined.
The contributions of this study to the existing knowledge base could lead to
positive social changes in the public health and health care in Oman. The social change
element in this research would be that the findings could inform the design of preventive
strategies and policies to address the burden of CRC in Oman. Addressing the burden of
CRC in Oman has implications for population health and economic progress. For
example, improved survival for CRC patients means longer disease free periods which
would allow them to return to work and become productive members of their
communities once again. Positive social change would also be achieved when preventive
measures to tackle the burden of CRC leads to reduction in the direct and indirect costs
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associated with CRC diagnosis and treatment. CRC treatment consists of surgeries,
chemotherapy, radiotherapy, inpatient and outpatient clinic visits for prolonged periods of
time. Direct costs of such care can range from $1941 to $48453 per patient per annum
depending on the stage of the disease at diagnosis (Wong et al., 2012).
In Chapter 3, the methodology and research design of this study as well as the
criteria for selecting the study population, sampling method, recruitment protocol, data
collection, and data analysis are presented. Additionally, the ethical considerations and
threats to validity as applicable are summarized.
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Chapter 3: Research Method
The purpose of this retrospective quantitative study was to examine the
association between T2DM and CRC risk and mortality in Oman. Based on the literature
review in Chapter 2, the following potential confounders were chosen a priori: age,
smoking status, alcohol consumption, BMI, cancer stage, diet, family history of CRC,
and physical activity. These are covariates that have been linked with CRC risk and
outcomes. The results of study may lead to positive social changes in the public health
and health care in Oman. The findings may inform the design of preventive strategies and
policies to address the burden of CRC in Oman. Addressing the burden of CRC in Oman
has positive implications for the population health and economic progress. In this chapter,
the methodology for this quantitative study will be explained in detail, including the
following sections: research design and rationale, setting and sample, instrumentation and
materials, data collection and analysis, protection of participants’ rights, threats to
validity, as well as the ethical procedures.
Research Design and Rationale
In this retrospective quantitative research, I used de-identified archival data from
the EHRs of CRC cases diagnosed and treated in Sultan Qaboos University Hospital
Oman from 2006 to 2016. The goal of the research was to examine the association
between T2DM and CRC risk and survival rates in Oman. To answer Research Question
1, a retrospective, case-control study was used to study the association between T2DM
and CRC risk. Data for this case-control study were extracted from the database of a
previous study in SQUH on lifestyle–related risk factors for gastrointestinal cancers in

55
Oman. This study included 120 CRC cases (ICD 10: 18.0 [Caecum)], 18.2 [ascending
colon], 18.3 [hepatic flexure], 18.4 [transverse colon], 18.5 [splenic flexure], 18.6
[descending colon], 18.7 [sigmoid colon], 18.8 [overlapping lesion of the colon], 18.9
[colon unspecified], 19 [recto-sigmoid junction], 20 [rectum[, and 28 stomach cancer)
patients admitted in the oncology wards or who attended the oncology outpatient clinic
from February 2016 to November 2016. The controls were 172 patients admitted in the
ENT, orthopedic surgery, and ophthalmology departments of the same hospital within the
period of the study. The controls were admitted with a wide range of acute nonmalignant
conditions that ranged from cataract, slipped discs, low back pain, simple fractures,
sprains, minor traumas, hernia repair, acute appendicitis, gall bladder stones, and
osteoarthritis. Dietary information was captured with a validated intervieweradministered, semi quantitative Food Frequency Questionnaire that had been tested for
reliability and validity (Arafa, Waly, Jriesat, Al Khafajei, & Sallam, 2011). The
reproducibility study for this questionnaire yielded intraclass correlations that ranged
from 0.56 to 0.88 among food groups (Pietinen et al., 1988). The validity study was
conducted on 190 men of similar age and yielded correlations between nutrient intake
values that ranged from 0.40 for selenium to 0.80 for alcohol (Pietinen et al., 1988).
Participants were asked to report the frequency and portion sizes for each of 33 food
items in six food groups commonly eaten in Oman, 2 years prior to CRC diagnosis for
cases or prior to their admission for controls. The questionnaire also contained questions
on demographic variables, such as gender, age, education and marital status, smoking and
alcohol consumption, as well as questions on the frequency of participation in selected
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physical activity aimed at achieving the physical activity levels recommended by the
WHO for adults, 18-64years and 65 years and over (WHO, 2016b). Upon receiving
approval to conduct research from the Walden University Institutional Review Board, the
de-identified data of CRC cases and controls from this study were extracted and stored in
a secured database in a password-protected personal computer.T2DM cases in this data
set were compared with controls with T2DM while controlling for diet, physical activity,
BMI, alcohol consumption, smoking status, and family history of CRC to determine the
odds of CRC in cases versus controls. Case-control studies are best suited for studying
rare diseases such as CRC and have been applied by similar studies in the past (Kuriki,
Hirose, & Tajima, 2007; Levi et al., 2002; Pelucchi et al., 2010; Sandhu et al., 2001).
Moreover, a hospital–based, case-control study provides an optimal framework for
comparing medical histories of both cases and controls (Kuriki et al., 2007; Levi et al.,
2002).
For Research Questions 2 and 3, a survival analysis was conducted using
secondary data from the hospital records of CRC patients diagnosed and treated in SQUH
Oman from 2006 to 2012. Cases were retrospectively followed up till 2016 to determine
the effects of T2DM on overall survival (OS). Vital status of cases was ascertained
through a review of the medical records of cases. Those who were still alive at the end of
the follow-up period were censored. Survival analysis was carried out with the Kaplan
Meier method. The differences in survival curves in patients with T2DM compared to
those without T2DM was determined with the Log-rank test. A multivariable-adjusted
Cox proportional hazards modeling was then performed while controlling for tumor
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location, gender, age group, family history of CRC, cancer stage, BMI, smoking, and
alcohol.
Methodology
Study Population and Setting Population
The study population for this research were male and female patients with
histologically confirmed diagnosis of CRC, according to the international Classification
of Diseases ICD-10, namely C18.0, 18.2, 18.3, 18.4, 18.5 18.6, 18.7, 18.8, 18.9, and C19
and C20, treated in SQUH from 2006 to 2016. The histological subtypes represented by
the ICD codes above are caecum, ascending colon, hepatic flexure, transverse colon,
splenic flexure, colon, sigmoid colon, overlapping lesion of the colon, colon unspecified,
recto-sigmoid junction, and-rectum respectively. For the purposes of this study and to
answer Research Questions 2 and 3, tumors labeled as histological types C18.0 to C18.9
were designated as colon subsite whereas, tumors labelled as C19 and C20 represented
the rectum subsite.
The controls (for Research Question 1) were patients admitted in the ENT,
orthopedic surgery, and ophthalmology departments of the same hospital within the
period of the study with a range of acute nonmalignant conditions that ranged from
cataract, slipped discs, low back pain, simple fractures, sprains, minor traumas, hernia
repair, acute appendicitis, gall bladder stones, and osteoarthritis. Permission to acquire
and analyze this de-identified data was obtained from the SQUH Institutional Review
Board after signing a data use agreement.
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Patients who were included in this study were adults aged 18years and above at
the time of diagnosis. Only patients with adenocarcinoma of the colon or rectum were
included. Patients diagnosed with other rarer types of colorectal malignancy, such as
lymphoma, gastrointestinal stromal tumors, gastrointestinal carcinoid tumors, squamous
cell, small cell carcinoma, leiomyosarcomas, and melanoma were excluded. Likewise,
tumors arising from the appendix (ICD 10: C18.1) or from the anus (ICD 10: C21.0)
were not included. The operational definition of CRC for this study was according to the
International Classification of Diseases version 10, namely ICD 18.0, 18.2, 18.3, 18.4,
18.6, 18.7, 18.8, 18.9 (colon cancer) and, ICD 19 and 20 (cancer of the rectum).
Malignant neoplasm of the appendix (ICD 18.1) are not considered a type of CRC
(American Cancer Society, 2016), and they were not included in this study.
The exposure variable was T2DM defined according to the WHO (year)
diagnostic criteria as a fasting plasma glucose ≥ 7.0mmol/l (126mg/dl) or 2–h plasma
glucose ≥ 11.1mmol/l (200mg/dl). T2DM status was determined through a review of
CRC patients’ case histories for a diagnosis of T2DM and from the patients’ drug use
summaries for information on glucose lowering medications as documented in the SQUH
EHRs.
Sampling and Sampling Procedures
A nonprobability sampling strategy was applied in this study. It involved a
convenience sampling method of all of the CRC cases aged 18 years and above,
diagnosed from 2006 to 2012 in the SQUH database. The OpenEpi software version
3.1.9.2 (Dean, Sullivan, & Soe, 2009) was used to calculate the sample size to address
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Research Question 1. The sample size for Research Questions 2 and 3 was determined
with the PS power software (Cunningham, & McCrum-Gardner, 2007; Dupont &
Plummer, 1990).
For Research Question 1, sample size calculation carried out with the OpenEpi
software yielded a sample size of 228 (114 in each group) based on 95% confidence
interval, 80% power, a 15% diabetes prevalence in controls (IDF, 2015), and a least odds
ratio of 2.5. For Research Questions 2 and 3, the PS power software (Dupont & Plummer,
1990) was used to calculate the required sample size. Based on 80% power, an accrual
interval of 6-time units, additional follow-up of 4-time units after the accrual interval, and
a hazard ratio of 1.5 in CRC subjects with T2DM relative to those without T2DM (De
Bruijn et al., 2013), a sample size of 206 was needed to be able to reject the null
hypothesis. However, the entire CRC cases available in the dataset within the study
period- 2006-2012 were 214, and this served as the sample. The de-identified data were
received from SQUH as two separate datasets after signing a data use agreement and
upon obtaining the Walden University IRB approvals. The datasets were then stored in a
secured database in a password-protected computer.
Operationalization of Study Variables
Incident CRC was the dependent variable for Research Question 1. CRC mortality
was the dependent variable for Research Questions 2 and 3. T2DM was the independent
variable (IV). The covariates for Research Question 1 were age, smoking status, alcohol
consumption, BMI, diet, family history of CRC, and physical activity. Research Question
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2 was adjusted for these potential confounding variables and additionally for tumor
location, gender, and stage of disease.
CRC was defined according to the ICD version 10, namely malignant neoplasm
of the colon ICD 18, malignant neoplasm of the recto-sigmoid junction, ICD19, and
malignant neoplasm of the rectum, ICD 20. The histological types for colon cancer
subsite included 18.0, 18.2, 18.3, 18.4, 18.5, 18.6, 18.7, 18.8, and 18.9, but excluded
malignant neoplasm of the appendix (ICD 18.1).
Tumor location referred to the anatomical site of tumor, and it was categorized
broadly as colon (ICD 18.0 18.2, 18.3, 18.4, 18.5, 18.6, 18.7, 18.8, 18.9) and rectum
(ICD19 and 20). Age was defined as the chronological age of the patient at the time of
diagnosis, and it was captured as a continuous variable. However, prior to the analyses,
age was recoded into a categorical variable, age group with three levels: ≤ 40, 41 – 60,
and ≥ 61 based on observational studies that CRC tended to occur in Omanis at younger
age than found in the Western countries (Brim et al., 2008; Kumar et al., 2015; Muliira et
al., 2016). Family history referred to a family history of CRC, and it was dichotomized as
yes/no. Physical activity defined as achieving the WHO (2015) standard recommendation
of 150 minutes of moderate physical activity or 75 minutes of vigorous physical activity
in a week for adults of ages 18-64 years and age 65years and above was dichotomized as
active/not active. The not active category comprised participants who reported less than
the WHO-recommended standard. The active category was made up of participants in the
moderate and vigorous physical activity groups in the original study. Smoking status
(ever and never smokers) and alcohol consumption (ever and never drank) were
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dichotomized as yes/no. Obesity was denoted by BMI, and it was categorized into three
levels: 18.5- 24.99 kg/m2, 25 - 29.99 kg/m2, ≥30 kg/m2 according to the WHO (2015)
criteria. The dietary data were available as servings per day or per week across the six
food groups (fruits, vegetables, proteins, milk products, grains, and oils) in the USDA
food guide 2010. There were also responses to consumption of cake/biscuits/white bread
and consumption of energy and sugary drinks. I created a categorical variable, diet
quality, with three levels: poor, fair, and good. I then converted participants’ responses in
the dietary questionnaire into Healthy Eating Index component scores, a set of scores that
capture the key recommendations of the 2010 USDA dietary guidelines (Guenther et al.,
2013). The HEI 2010 components are scored to derive a single score out of a possible
100 maximum points. Each participant’s score could fall within a range of 30-100 points.
A diet with a score greater than 80 is considered good, with a score of 51-80 is
considered fair, and one with a score of less than 51 is considered poor quality
respectively (Guenther et al., 2013). The participants’ composite scores were used to
group them into one of the three categories of diet quality. The study variables and their
level of measurement are as shown in Table 2.
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Table 2
Study Variables and Their Level of Measurement
Variable

Type

Level of measurement

T2DM

Independent

Nominal (yes =1, no =0)

Tumor location

Independent

Nominal colon (yes/no), rectum
(yes/no)

Year of diagnosis

Independent

scale

Stage of disease

Independent

Ordinal (1- local, 2 = regional
spread, 3 = distant spread)

Body Mass Index

Independent

Ordinal
1= 18.5- 24.99 kg/m2
2= 25 - 29.99 kg/m2
3= ≥30 kg/m2

Diet Quality

Independent

Ordinal
Poor
Fair
Good

Physical activity

Independent

Nominal (active/not active)

Alcohol use

Independent

Nominal ( ever =1, never = 0)

smoking status

Independent

Nominal (ever =1never = 0)

Age Group

Independent

Ordinal
1= ≤40
2= 41-60
3= ≥61

Family history of

Independent

Nominal (yes =1, n =0)

Incident CRC

Dependent

Nominal (yes/no)

CRC mortality

Dependent

Nominal (yes/no)

CRC
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Data Analysis Plan
The International Business Machine Corp. (IBM) SPSS Statistics version 21 was
used to conduct all analyses. First, the data sets were cleaned through a validation process
in SPSS using the predefined rule option. This process allowed me to identify missing
data, extreme values (outliers), duplicates, and multiple entries (Green & Salkind, 2003).
I then created a codebook where I documented the relevant variables for both the
descriptive and inferential analyses. The various steps necessary for all my analyses were
also detailed in this codebook.
Data analysis started with descriptive analysis to determine the characteristics of
the two datasets and the distribution of the relevant variables. The main independent
variable T2DM, and all other covariates, were categorical variables; therefore, the chisquare test assumption was first tested to ensure it was not violated. Following the testing
of the chi-square test assumption, chi-square test of association was calculated to
determine differences among relevant variables between the group with T2DM compared
with the no T2DM group both for the case control study and the time-to event analysis.
For the purpose of conducting the survival analysis for Research Questions 2 and 3, the
Cox proportional hazard assumption was tested for T2DM and all other covariates using
the log-log function in the Kaplan Meier plots and the time-covariate Cox proportional
regression. Multivariable-adjusted logistic and Cox proportional regression analyses were
then carried out to determine the association between T2DM and CRC risk and survival
rates. The aim of the research questions for this study was to meet the key objectives of
investigating the possible influence of T2DM on the risk of developing CRC and on CRC
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survival rates in the Omani population. The following relevant covariates (age, stage of
disease, gender, diet, BMI, physical activity, alcohol consumption, smoking status, and
family history of CRC) were adjusted for. On completing the descriptive analyses
described above, inferential statistics was conducted to answer the research questions.
Research Question 1
What is the association between T2DM and risk of developing CRC in Oman,
while controlling for, diet, BMI, physical activity, alcohol consumption, smoking status,
age, and family history CRC?
H01: There is no association between T2DM and risk of CRC in Oman while
controlling for, diet, BMI, physical activity, alcohol consumption, smoking status, age,
and family history.
Ha1: There is an association between T2DM and risk of CRC in Oman while
controlling for, age, diet, BMI, physical activity, alcohol consumption, smoking status,
and family history of CRC.
To answer this question, I carried out a multivariable-adjusted logistic regression
to determine the odds of developing CRC in cases and controls with T2DM. The
variables that were controlled for were diet, physical activity, BMI, alcohol consumption,
smoking status and family history of CRC. According to epidemiological studies
(Aleksandrova et al., 2014; Cavicchia et al., 2013; Jarvandi et al., 2013; Kirkegaard et al.,
2010; Pelucchi et al., 2010; Tabung , Steck, Ma, et al., 2015), these are potential effect
modifiers and confounding factors of this association. Odds ratio with corresponding
95% confidence intervals were determined at a statistical significance of 0.05.
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Research Question 2
What is the association between T2DM and CRC survival rates in Oman?
H02: There is no association between T2DM and survival rates in CRC in Oman.
Ha2: There is an association between T2DM and survival rates in CRC in Oman.
To answer this question, I calculated overall survival time in months for each
participant by subtracting the date of diagnosis from the date of death, loss to follow up
or end of study (which ever was earliest). I generated and compared Kaplan Meier curves
for CRC patients with T2DM and those without T2DM using survival time in months as
the time indicator and the vital status (1 = death, 0 = censored) as the survival indicator.
Then, I conducted log rank test to determine if there were any differences in survival
rates between CRC patients with T2DM and those without T2DM.
Finally, I conducted a multivariable–adjusted Cox proportional regression
analysis while controlling for tumor location, gender, age, family history of CRC, cancer
stage, body mass index, smoking status and alcohol consumption. These are covariates
that have been shown in the literature to have prognostic effect on CRC and were chosen
a priori. The hazard ratio and corresponding 95%confidence interval was generated at
statistical significance of less than 0.05.
Research Question 3
What is the association between T2DM and CRC survival rates in Oman
stratified by gender, age group, tumor location and cancer stage in Oman while
controlling for the following relevant covariates: smoking status, alcohol consumption,
BMI, diet, physical activity and family history of CRC?
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H03: There is no association between T2DM and CRC survival rates in Oman
stratified by gender, age group, tumor location and cancer stage in Oman while
controlling for the smoking status, alcohol consumption, BMI, diet, physical activity and
family history of CRC.
Ha3: There is an association between T2DM and CRC survival rates in Oman
stratified by gender, age group, tumor location and cancer stage in Oman while
controlling for the following relevant covariates: smoking status, alcohol consumption,
BMI, diet, physical activity and family history of CRC.
To answer this question, I conducted Kaplan Meier survival analysis stratified by
gender, age group, tumor location and cancer stage. The log rank test of equality of
differences in survival rates between the groups with and without T2DM was also
conducted across strata of these covariates. Then, I conducted multivariable- adjusted
Cox regression analysis with interaction terms for T2DM and each of the strata variables
to determine if any of them modified the association between T2DM and CRC. Hazard
ratios and their corresponding 95%confidence intervals were derived at a statistical
significance of less than 0.05.
Threats to Validity
According to (Szklo & Nieto, 2014. pp. 109-150), a valid study should be fit for
purpose and the data collected in a reliable and valid manner. Only then can the overall
results of the study be said to be unbiased and closer real life situation. However, it is
difficult to achieve ideal situations in epidemiological studies. This research was a nonrandomized study that used secondary data from SQUH and a nonprobability
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convenience sampling method. Potential threats to both internal and external validity
include recall bias, selection bias, reporting bias and misclassification of exposure bias.
External Validity
External validity threats bothered on the fact that data from this study was from
one of two hospitals that treat cancer patients in Oman and so the results may not be
generalized. However, SQUH treats more than 50% of CRC cases in Oman. Moreover,
many patients prefer to have their treatment in SQUH, claiming that there are better
facilities in SQUH than in the other hospital. Therefore, the samples were to a large
extent, representative of the Omani population.
Internal Validity
The data set that addressed Research Question1 included dietary data derived
from responses to a food frequency questionnaire. It is possible that the CRC cases may
not have accurately recalled their dietary habits. Secondly, misclassification of exposure
is common in case –control studies. In this study if participants were unable to accurately
recall past exposure to diet and lifestyle habits (recall bias) it could result in
misclassification of their exposure status.
Another type of misclassification bias inherent in this secondary data would be if
interviewers deviated from study protocols (Szklo & Nieto, 2014. pp.109-150). Research
Question1 was addressed with a hospital-based case control study. A particular selection
bias that is inherent in hospital-based case control studies is the Berkson’s bias (hospitalpatient selection bias). Berkson’s bias is a systematic bias in the distribution of disease
amongst hospitalized patients such that in case-control studies where both cases and
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controls are selected from the hospital, the controls tend to be more likely exposed to the
exposure under consideration than the general population from which the cases came
from (Schwartzbaum, Ahlbom, & Feychting, 2003; Roberts, Spitzer, Delmore, & Sackett,
1978). However, the controls were chosen from among patients admitted to the same
hospital for conditions that are unrelated to the case disease therefore, the potential for
Berkson’s bias would be minimal.
Construct Validity
Construct validity was another inherent threat in this study. This would arise if the
instrument that was used to collect the diet and lifestyle information from the participant
is not a validated instrument. However, the instrument used has been tested for validity,
reproducibility and reliability (Arafa et al., 2011). The reproducibility study for this
instrument utilized a sample of 121 men aged 55–69 years and yielded intraclass
correlations that ranged from 0.56 to 0.88 among food groups (Pietinen et al., 1988;
Rimm et al., 1992). The validity study was conducted on 190 men of similar age and
yielded correlations between nutrient intake values that ranged from 0.40 for selenium to
0.80 for alcohol (Pietinen et al., 1988; Rimm et al., 1992).
Statistical conclusion validity threat could have occurred if the appropriate sample
size was not calculated for both samples. However, the sample size was calculated and
triangulated with two different statistical software, OpenEpi and PS Power software.
Finally, unknown confounding factors to both T2DM and CRC that were not accounted
for during the analysis could have affected the internal validity of this study.
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Ethical Procedures
All possible violation of participants’ rights was avoided by taking appropriate
measures to minimize any possibility of disclosure of personal information. Thus, on
receipt of the de-identified archival data from SQUH, I stored the datasets in a passwordprotected personal computer dedicated to this doctoral research. An additional copy of
the datasets was created and stored in a separate, secure location to prevent loss due to
natural disaster. Secondly, this study did not require direct participation of patients or use
of live subjects. Thirdly, the datasets were not accessed until the Walden University
Institutional Review Board approval was obtained. Additional verification of data during
the data cleaning stage of the analysis was obtained with the help of a staff member of the
IT unit of SQUH who was specifically assigned to monitor what I was doing.
Summary
This quantitative retrospective case control and time-to-event analysis was carried
out with the intention to examine the association between T2DM and CRC risk and
mortality in Oman. The purpose of the study is to contribute to the current body of
knowledge on this topic with the use of archival data from SQUH. Two methods for
power analysis were triangulated to arrive at the appropriate sample size for the study.
Upon receiving approval from the Walden University IRB, the required data sets were
collected from SQUH and abstracted and stored in a password-protected personal
computer. Descriptive and inferential analyses of the data were then conducted.
The inferential analyses focused on examining the possible association
betweenT2DM and the risk of developing CRC, and CRC mortality while adjusting for
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the following important covariates: age, gender, BMI, physical activity, diet, alcohol
consumption and smoking status. The likely threats to validity were selection bias,
reporting bias and recall bias. Appropriate ethical procedures including the approval from
the Walden University IRB were addressed. Data analysis was carried out with the SPSS
version 21 (2012) software. The results of this study are as presented in Chapter 4.
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Chapter 4: Results
The purpose of this retrospective, quantitative study is to examine the association
between T2DM and the risk and survival rates of CRC in Oman while controlling for
covariates, such as stage of disease, gender, diet, BMI, physical activity, alcohol
consumption, smoking, age, and family history of CRC. The research questions and
hypotheses are as follows:
1.

What is the association between T2DM and the risk of developing CRC in
Oman?

H01: There is no association between T2DM and CRC risk in Oman.
Ha1: There is an association between T2DM and CRC risk in Oman.
2.

What is the association between T2DM and CRC survival in Oman?

H02: There is no association between T2DM and CRC survival rates in Oman.
Ha2: There is an association between T2DM and CRC survival rates in Oman.
3.

What is the association between T2DM and CRC survival stratified by
gender, age group, tumor location, and cancer stage in Oman?

H03: There are no differences in the association between T2DM and CRC survival
rates by gender, age group, tumor location, and cancer stage, in Oman.
Ha3: There are differences in the association between T2DM and CRC survival
rates by gender, age group, tumor location, and cancer stage, in Oman.
This chapter will include a discussion about data collection and an explanation of
any discrepancies in data from the data analysis plan discussed in Chapter 3. Descriptive
statistics of the sample will be presented in narrative and tabular form. The findings from
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the analysis will also be provided in this chapter. This will include detailed descriptive
statistics, evaluation of statistical assumptions, and answers to the research questions. The
overall findings will then be summarized before proceeding to Chapter 5.
The data used in this study were provided by the SQUH. They were extracted
from the EHRs of CRC patients treated in SQUH. The de-identified data for all CRC
patients treated between 2006 and 2016 in the hospital were given to me in a flash drive
by the director of the hospital information system after signing a data use agreement.
Upon receiving approval to begin research from the Walden University IRB, I opened the
storage device containing the data sets. On examination, the flash drive contained two
files in Excel format. The first file was labelled CRC_Lifestyle and contained variables
used for a previous hospital-based, case-control study. This was the dataset that was used
to address Research Question 1. The second file was labelled CRC_All and contained all
CRC cases treated in SQUH from 2006 to 2016. This was the dataset that was used to
answer Research Questions 2 and 3.
Data Cleaning
Dataset for Research Question 1
This dataset was expected to contain information on 120 CRC and 28 gastric
cancer patients and 172 controls. On opening the CRC_Lifestyle data set, I discovered
that there were 125 CRC cases, 28 gastric cancer cases, and 170 controls. First, the
gastric cancer cases were deleted, and the reduced dataset was saved as CRC sample for
Research Question 1. On further inspection of the reduced dataset, I found that out of the
125 CRC cases, three were primary pancreatic cancer cases, seven were cancer of the
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duodenum, and one case was cancer of the appendix. These 11 cases were deleted
because cancers of the appendix; duodenum and pancreas were not in the predefined
inclusion criteria. This left me with a final sample of 114 CRC cases and 170 controls for
Research Question 1. The predefined sample size necessary to reject the null hypothesis
was of 228 (114 in each group). The data were exported from the Excel format to SPSS
21.
A frequency check on the variables was performed to look for missing values and
outliers. All relevant variables to address Research Question 1 were included in the
dataset. However, BMI information was missing for eight controls. In order not to
compromise statistical power by deleting the entries with missing BMI values (this would
lead to a reduction in sample size), the sex-specific mean BMI was imputed for the
missing values. Hence, the final sample for Research Question1 remained as 114 CRC
cases and 170 controls. In further inspection of the BMI of participants, I found that only
nine cases and two controls were in the underweight category; therefore, BMI was
collapsed into a categorical variable with three levels: underweight/normal, overweight,
and obese categories.
Age was originally categorized into seven age groups. However, due to few cases
in some of the categories, age group was further collapsed into three categories: ≤40, 4160, and ≥61. Physical activity responses were available as not active (did not engage in
any physical activity), moderately active (engaged in activities like walking), and
vigorously active (engaged in activities like running, aerobics, and cycling), representing
participants who did not engage in any physical activity, those who devoted up to 150
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minutes of moderate physical activity per week, and those who put in 75 minutes of
vigorous physical activity per week according to the WHO (2016b) standard
recommendation for adults. I categorized physical activity into two categories as active
and not active categories. The not active category included participants who reported
no/less than the WHO-recommended standard physical activity for adults. The active
category included participants in the moderate and vigorous physical activity groups in
the original dataset.
Dietary responses were available as servings per day or per week across the six
food groups (fruits, vegetables, proteins, milk products, grains, and oils) in the USDA
food guide 2010. There were also responses to consumption of cake/biscuits/white bread
and consumption of energy and sugary drinks. I constructed another variable (dietary
score) using the Healthy Eating Index (HEI 2010). The HEI-2010 components are a set of
scores that capture the key recommendations of the 2010 USDA dietary guidelines
(Guenther et al., 2013). The HEI 2010 components are scored to derive a single score out
of a possible 100 points. A diet with a score greater than 80 is considered good, one with
a score of 51-80 is considered fair, and one with a score of less than 51 is considered poor
(Guenther et al., 2013). I summed up scores for each participant across the six main food
groups according to the HEI standards. Those who consumed servings within the USDArecommended serving per day received 10 full points whereas those who consumed more
or less than the recommended serving were assigned 5 points (half the maximum points).
In addition to the scores for the main food groups, a score of 0 or 20 was assigned for
participants who documented that they consumed (0 points) or did not consume (20
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points) cakes, biscuits, white bread, and those who consumed (0 points) or did not
consume (20 points) energy and soft drinks, according to the HEI 2010 scoring standards.
With these scoring standards, participants’ total dietary score could fall within the range
of 30 to 100 points. I then summed up scores for each participant and, depending on the
HEI scores, participants were assigned to one of three categories of the diet quality: poor,
fair, and good. The HEI-2010 has been used as a tool for assessing changes in diet quality
over time, examining the relationship between diet cost and diet quality, and in research,
to better understand relationships between nutrients/or dietary patterns and health-related
outcomes (Guenther et al., 2013). Family history of colorectal cancer was categorized as
yes/no. Likewise, smoking and alcohol intake were categorized as yes/no.
Dataset for Research Questions 2 and 3
This dataset contained all CRC cases treated in SQUH from 2006 to 2016. The
variables in this data set included demographic variables, diagnosis (colon/rectum), date
of diagnosis, comorbidities (hypertension, congestive heart failure diabetes), height in
meters, weight in kilograms, stage and grade of disease at diagnosis, and type of
treatment. The data were inspected, and all relevant variables to address Research
Questions 2 and 3 were present in the dataset. However, some of the cases were
diagnosed as far back as 2002. These cases (n= 32) were deleted in line with the
predefined inclusion criteria. This left me with a sample of 228 cases to conduct the
analysis. The calculated sample size based on 80% power, an accrual interval of 6-time
units, additional follow-up of 4-time units after the accrual interval, and a hazard ratio of
1.5 in CRC subjects with T2DM relative to those without T2DM (De Bruijn et al., 2013),
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was 206. Therefore, this available sample size of 228 was sufficient to address Research
Questions 2 and 3.
I was granted access to the patients’ EHR under the supervision of a staff member
of the hospital information system. This enabled me to gather information related to
smoking, alcohol consumption, and vital status for these 228 patients over the entire
study period. Information about diet and exercise was available for only 42 patients.
Therefore, a separate descriptive analysis was conducted with this subset of patients to
see if their characteristics differed from the rest of the sample.
Height in meters and weight in kilograms were available for each patient. BMI
was then calculated for each patient by dividing weight in kilograms by the square of
height in meters. BMI as a continuous variable was normally distributed. Similar to
Research Question1, BMI was converted into a categorical variable, BMIcat, with three
categories: underweight/normal, overweight, and obese categories. Age was available as
a continuous variable and was then converted into age group, a categorical variable with
two categories: ≤ 60 years and ≥ 61 years. Cancer stage was categorized as local (for
localized disease), regional spread (disease had spread to lymph nodes), and distant
spread (disease has metastasized to distant organs); T2DM was categorized as T2DM and
no T2DM; and family history of CRC was categorized as yes/no. Similarly, smoking,
alcohol consumption, diet, and physical activity were as categorized in the sample for
Research Question 1.
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Data Analysis
The Chi-Square Assumption
In the two samples for Research Question 1 and Research Questions 2 and 3, the
age and BMI variables were converted into categorical variables (as described above)
before conducting the analyses. All other variables necessary for answering the research
questions were categorical. The chi-square test was therefore used to assess the
distribution of these participant characteristics among cases and controls for Research
Question 1, and among cases with T2DM or without T2DM for Research Questions 2
and 3. The assumptions of the chi-square test require that the sample size be large enough
such that none of the cells in the contingency table has expected counts of less than 5
(Field, 2013). The expected frequencies in each cell were greater than 5, and the sample
sizes were sufficiently large, indicating that the conditions for the chi-square assumption
were met.
Proportionality of Hazards Assumption
For the purposes of conducting the survival analysis, Cox proportional hazard
modelling was applied to answer Research Questions 2 and 3. I tested the proportionality
of hazards assumption, a major assumption for the Cox proportional hazards model. This
assumption requires that the effect of a given set of covariates be the same over time or
that the shape of the survival function is the same for all cases or groups over time
(Tabachnick, Fidell, & Osterlind, 2001, pp. 510-570). If this assumption is violated, then
the result of the analysis cannot be said to be valid. To graphically assess this assumption,
I generated Kaplan Meier log-log curves separately for each predictor variable. For this
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assumption to hold, the log-log plot should show separate lines for the variable that is
being compared. As an example, the log-log curve for patients with and those without
T2DM is presented in Figure 2. Similar log-log function curves were also generated for
other covariates (Appendix A). I also conducted a time-dependent covariate Cox
regression to determine if the effect of T2DM and other independent variables on CRC
survival was time dependent. The result of this analysis is shown in Table 3. The p-values
in Table 3 indicate that the effect of the variables on CRC survival was not time
dependent.

Figure 2. Log-log function for T2DM

79
Table 3
Test of Proportionality Hazard for Time*Covariates
Variable

B

SE

Wald

P

ExpB

95% CI for Exp (B)
LL

UL

T_COV_

0.00

0.01

0.00

.10

1.00

0.99

1.01

T2DM

0.11

0.34

0.11

0.74

1.12

0.58

2.18

T_COV_

-0.01

0.01

0.70

0.40

0.99

0.98

1.01

Gender

0.44

0.32

1.93

0.17

1.55

0.84

2.89

T_COV_

0.00

0.00

2.77

0.09

1.00

0.99

1.01

Location

-0.17

0.11

2.43

0.12

0.84

0.68

1.05

T_COV_

-0.01

0.00

2.70

0.10

0.99

0.97

1.00

Age group

0.54

0.33

2.76

0.10

1.72

0.91

3.24

T_COV_

-0.00

0.01

0.35

0.55

1.00

0.99

1.01

Cancer

0.98

0.25

15.00

0.00

2.66

1.62

4.36

T_COV_

-0.002

0.009

0.03

0.84

0.1

0.98

1.02

FH

-0.2

0.42

0.02

0.64

0.82

0.36

1.88

T_COV_

-0.00

0.01

0.36

0.55

1.00

0.99

1.01

BMI

-0.13

0.20

0.40

0.53

0.88

0.59

1.31

T_COV_

-0.00

0.12

0.23

0.63

0.99

0.96

1.02

Alcohol

0.16

0.56

0.08

0.78

1.17

0.39

3.51

T_COV

0.01

0.01

0.18

0.67

1.01

0.98

1.03

Smoking

0.27

0.50

0.30

0.58

0.76

0.29

2.01

T_COV_

0.00

0.01

0.00

.10

1.00

0.99

1.01

Stage
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Study Results
Descriptive Statistics
Research Question 1:. Descriptive statistics stratified by cases and controls was
carried out with the final sample (n= 284) for Research Question 1. Chi-square tests were
used to compare differences in categorical and binary variables between cases and
controls. Table 4 contains descriptive statistics and summary characteristics of cases and
controls in this sample. According to the descriptive analysis, there were differences in
the gender distribution of the cases and controls. Whereas there were more males among
cases (58.8%) than in controls (44.7%), females were more among controls (55.3%) than
in cases (41.2%). This table also shows that about half (49.4%) of controls were
overweight, and there were more obese cases than controls (28.1% vs 26.5%). In
addition, the table also reveals that 48.2% of the cases consumed good quality diet
according to the USDA food guide and HEI 2010 standards and 15.8% of cases had a
family history of CRC. There were no statistically significant differences between cases
and controls with respect to age, smoking, alcohol consumption, and physical activity.
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Table 4
Characteristics of the Final CRC Sample for RQ1 by Case-Control Status
CRC case

control

(N = 114)

(N = 170)

N (%)

N (%)

P value

≤40

15 (13.2)

36 (21.2)

0.08

41-60

48 (42.1

78 (45.9)

>60

51 (44.7)

56(32.9)

Male

67 (58.8)

76 (44.7)

Female

47 (41.2)

94 (55.3)

No

86 (75.4)

131(77.1)

Yes

28 (24.6)

39 (22.9)

No

98 (86.0)

148 (87.1)

Yes

16 (14.0)

22 (12.9)

Not Active

59 (51.8)

96 (56.5)

Active

55 (48.2)

74 (43.5)

Variable
Age group

Gender

0.02a

Smoking

0.43

Alcohol

0.46

Physical activity

Table continues

0.24
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CRC case

control

(N = 114)

(N = 170)

N (%)

N (%)

48 (42.1)

41 (24.1)

34 (29.8)

84 (49.4)

32 (28.1)

45 (26.5)

Poor

8 (7.0)

18 (9.2)

Fair

51 (44.7)

95 (55.9)

Good

55 (48.2)

57 (33.5)

No

96 (84.2)

159 (93.5)

Yes

18 (15.8)

11 (6.5)

0.01d

No

77 (67.5

107 (67.9)

0.25

Yes

37 (32.5)

63 (37.1)

Variable

P value

Body Mass Index (Kg/m2)
Underweight/Normal (<
25kg/m2)
Overweight (25 - 29.99

0.01b

kg/m2)
Obese (≥30 kg/m2)
Diet

0.04c

Family History of CRC

T2DM

Note. a: x2 =5.49, df (1), b: x2 = 13.41 df (2), c: x2 = 6.35, df (2), d: x2 = 6.463, df (1)
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Research Questions 2 and 3: The sample contained a total of 228 CRC patients
of which 72 (31.6%) had T2DM compared to 156 (69.4%) without T2DM. Table 5 shows
the descriptive characteristics of the patients by T2DM status. There were almost equal
proportion of males (56.9% versus 59.6%) and females (43.1% versus 40.4%) in the 2
groups. In terms of tumor location, almost twice as many colon cancer patients had
T2DM (65.3%) compared to the rectal cancer patients (34.7%). More of the patients with
T2DM cases were in the younger age group of ≤ 60 years. However, there were more
cases with regional and distant metastasis in the nonT2DM group (33.3% and 44.9%)
compared to the T2DM group (36.1% and 37.5%). The table also shows that there were
statistically significant differences in BMI by T2DM status. The T2DM group was more
obese than the noT2DM group (37.5% compared to 22.4%) whereas there were more
underweight/normal weight cases in the noT2DM group. The T2DM group consumed
more alcohol (13.9%) compared to the noT2DM group (7.7%). Likewise, there were
more smokers in the T2DM group (16.7%) compared to the noT2DM group (14.1%). By
the end of the follow up period, the proportion of events was similar in the T2DM and
noT2DM groups (37.5% versus 35.9%). The proportion of censored cases was also
similar in the two groups (62.5% versus 64.1%).
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Table 5
Characteristics of the sample for RQs 2 and 3 by *T2DM status

Variable

T2DM

noT2DM

(N =72)

N =156)

N

%

N

%

P value

Male

41

56.9

93

59.6

0.41

Female

31

43.1

63

40.4

Colon

47

65.3

85

54.5

Rectum

25

34.7

71

45.5

Gender

Tumor
Location

Age Group

0.08

0.08

≤ 60

38

53.8

99

63.5

≥ 61

34

47.2

57

36.5

2006

14

19.4

36

23.1

2007

6

8.3

13

8.3

2008

6

8.3

23

14.7

2009

8

11.1

17

10.9

Year of
Diagnosis

Table continues

0.32
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T2DM

noT2DM

(N =72)

N =156)

Variable

N

%

N

%

2010

14

19.4

13

8.3

2011

9

12.5

20

12.8

Localized

19

26.4

34

21.8

Regional

26

36.1

52

33.3

Distant

27

37.5

70

44.9

Yes

15

20.8

28

17.9

No

57

79.2

128

82.1

18

25

62

39.7

27

37.5

59

37.8

P value

CRC stage

0.55

Family History
of CRC
0.36

Body Mass
Index (Kg/m2)
Underweight
/Normal (<25
kg/m2)
Overweight (25 29.99 Kg/m2)
Table continues

0.03
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Variable
Obese (≥30

T2DM

noT2DM

(N =72)

N =156)

N

%

N

%

P value

27

37.5

35

22.4

Yes

10

13.9

12

7.7

No

62

86.1

144

92.3

Yes

12

16.7

22

14.1

No

60

83.3

134

85.9

Dead

27

37.5

56

35.9

Censored

45

62.5

100

64.1

kg/m2)
Alcohol
consumption
0.11

Smoking
0.37

Status
0.46

Note. T2DM = fasting plasma glucose ≥ 7.0mmol/l (126mg/dl) or 2–h plasma glucose ≥
11.1mmol/l (200mg/dl). Localized = early disease stage, Regional = disease spread to
lymph nodes, Distant = disease spread to distant organs
Characteristics of the diet and physical activity subsample
Diet and physical activity data were available for only 42 patients in the sample
that addressed research questions 2 and 3. These two variables were therefore not
included in the multivariate adjusted models. Table 6 shows the descriptive statistics for
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this subsample. A comparison of the patient characteristics in this subsample with those
in the whole sample in table 5 reveal very little differences between the two groups
except that almost all the patients in the diet-physical activity subsample (90.5%) were
censored. The 9.5% that experienced the event had no T2DM. Moreover, more than half
(54.2%) of the diet-physical activity subsample were diagnosed in 2012 compared to
those in the sample without the diet and physical activity. This can be attributed to the
fact that the diet and exercise data were collected through personal interviews of patients
who came to the hospital. Patients were interviewed during their hospital visit between
February and November 2016. Given the natural cause of CRC, it is possible that patients
diagnosed earlier were too sick to be available for personal interviews. It is also possible
that earlier diagnosed patients were not alive to be part of those being interviewed about
their dietary and physical activity habits. It was worthwhile to conduct a separate analysis
of this subsample due to the small sample size. Therefore, I decided to discuss the
implications of the absence of diet and physical activity variables in the multivariateadjusted Cox regression models in chapter 5.
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Table 6
Characteristics of the diet and physical activity subsample (n= 42)
Variable

N

%

Male

28

66.7

Female

14

33.3

Colon

32

76.2

Rectum

10

23.8

≤40

5

11.9

41-60

17

40.5

≥61

20

37.6

2006

2

4.8

2007

2

4.8

2008

5

11.9

2009

1

2.4

2010

5

11.9

Gender

Tumor Location

Age Group

Year of Diagnosis

Table continues
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Variable

N

%

2011

5

11.9

2012

22

54.2

Localized

11

26.2

Regional Spread

15

35.7

Distant Metastasis

16

38.1

Yes

9

21.4

No

33

78.6

Yes

13

31.0

No

29

69.0

Underweight /Normal (<25 kg/m2)

11

26.2

Overweight (25 - 29.99 kg/m2)

15

35.7

Obese (≥30 kg/m2)

16

38.1

Stage of Disease

Family History of CRC

*T2DM

BMI

Table continues
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Variable

N

%

Poor

20

47.6

Fair

22

52.4

Active

17

40.5

Not active

25

59.5

Yes

4

9.5

No

38

90.5

Yes

8

19.

No

34

81.0

Dead

4

9.5

Censored

38

90.5

Diet

Good

Drinking

Smoking

Status

Note. T2DM = fasting plasma glucose ≥ 7.0mmol/l (126mg/dl) or 2–h plasma glucose ≥
11.1mmol/l (200mg/dl).
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Answering the Research Questions
The following inferential analyses were conducted for each of the three research
questions and associated hypotheses:
Research Question 1
What is the association between type 2 diabetes mellitus (T2DM) and the risk of
developing colorectal cancer (CRC) in Oman? The related null and alternative
hypotheses for this question were:
H01: There is no association between T2DM and CRC risk in Oman.
Ha1: There is an association between T2DM and CRC risk in Oman.
To answer this research question, multivariate logistic regression was carried out
to determine the association between T2DM and the dependent variable CRC while
controlling for cancer stage, gender, diet, body mass index, physical activity, alcohol
consumption, smoking and family history of CRC. These were variables selected a priori
based on my literature review. The models were systematically built by first fitting
T2DM alone (Model 1). This was followed by fitting a minimally adjusted model (model
2) with T2DM and age as the independent variables. Model 3 contained model 2 and the
interaction term for T2DM and age. Finally, a fully adjusted model that included model 3
plus other potential confounding variables mentioned above, was built. The result of this
analysis is as reported in Table 7.
The result shows that the final model was not statistically significant (OR = 1.49,
95% CI: 0.29-7.68, p = 0.64), indicating that, having adjusted for potential confounding
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variables, there is no statistically significant association between T2DM and CRC risk.
Therefore, the null hypothesis cannot be rejected.
Table 7
Logistic regression models for the association between T2DM and risk of CRC
OR

95% CI

P

Model 1

0.83

0.50-1.37

0.46

Model 2

0.73

0.43-1.22

0.23

Model3

1.25

0.27-5.83

0.78

Model 4

1.49

0.29 -7.68

0.64

Note. T2DM = fasting plasma glucose ≥ 7.0mmol/l (126mg/dl) or 2–h plasma glucose ≥
11.1mmol/l (200mg/dl), noT2DM is the referent group
Research Question 2
What is the association between T2DM and CRC survival rates in Oman? The
related null and alternative hypotheses for this question were:
H02: There is no association between T2DM and survival rates in CRC in Oman.
Ha2: There is an association between T2DM and survival rates in CRC in Oman.
To answer this question, overall survival time in months for each participant was
determined by subtracting the date of diagnosis from the date of death, loss to follow up
or end of study (which ever was earliest). CRC patients who died were coded as 1 and the
censored cases were coded as 0. Survival curves were generated using survival time in
months as the time indicator and the vital status (1 = death, 0 = censored) as the survival
indicator. The Kaplan Meier curves for CRC patients with T2DM and those without
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T2DM were generated and compared (Figure 3). The log rank test was conducted to
determine if there were any differences in survival rates between CRC patients with
T2DM and those without T2DM. Table 8 shows that the median survival for CRC
patients with T2DM was 113.2 months compared to 115.2 months for those without
T2DM. The log-rank test, χ2 (1) = .24, p = 0.63 was not statistically significant (Table 9).
This indicates that there is no difference in survival rates between the groups studied at
all time points in the study period.
Finally, a multivariate Cox proportional regression analysis was carried out while
controlling for tumor location, gender, age, family history of CRC, cancer stage, body
mass index, smoking and alcohol consumption. These are covariates that have been
shown in the literature to have prognostic effect on CRC and were chosen a priori. The
multivariate Cox regression models were built by first fitting T2DM, age and cancer
stage (model 1). Model 2 included model 1 plus all other covariates. The hazard ratio of
T2DM, adjusted for these potential confounding covariates is shown in Table 10. Results
from the multivariable-adjusted model (model 2) were not statistically significant (HR =
0.99, 95% CI: 0.62 -1.60, p = 0.99), indicating that, having adjusted for potential
confounding variables, there is no statistically significant association between T2DM and
CRC survival rates. Therefore, the null hypothesis cannot be rejected.
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Figure 3. Kaplan Meier survival curves of cases with T2DM compared to those
without T2DM
Table 8
Mean and median survival times by T2DM status
Mean

Median

T2DM

No of

Status

months

No

83.56

4.84

[74.07, 93.05]

Yes

86.34

6.60

Overall

84.65

3.93

SE

95% CI

No of

SE

95% CI

115.20

23.10

[68.17, 62.23]

[73.42, 99.27]

113.20

40.72

[33.40, 193.12]

[76.94, 92.35]

115.20

16.45

[82.97, 147.43]

months

Estimation is limited to the largest survival time if it is censored
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Table 9
Log rank test of equality of survival for CRC cases with and without T2DM.

Log Rank (Mantel-Cox)

Chi-Square

df

P value.

0.24

1

0.63

Test of equality of survival distributions for the different levels of T2DM
Table 10
Multivariable-adjusted Cox Regression Models for association between T2DM and CRC
survival
HR

95%CI

P value

Model 1

0.98

0.62-1.56

0.94

Model 2

0.99

0.62-1.60

0.99

Note. noT2DM = referent
Research Question 3
What is the association between T2DM and CRC survival stratified by gender,
age group, tumor location and cancer stage in Oman?
H03: There are no differences in the association between T2DM and CRC survival
rates by gender, age group, tumor location and cancer stage, in Oman
Ha3: There are differences in the association between T2DM and CRC survival
rates by gender, age group, tumor location and cancer stage, in Oman.
To test this hypothesis, I conducted Kaplan Meier survival analysis stratified by
gender, age group, tumor location and cancer stage. The log rank test of equality of
differences in survival rates between the groups with and without T2DM was also
conducted across strata of these covariates. Then, I conducted multivariable- adjusted
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Cox regression analysis with interaction terms for T2DM and each of the strata variables
to determine if any of them modified the association between T2DM and CRC. The first
model included gender, tumor location, cancer stage, age, and gender*T2DM. Followed
by gender, tumor location, cancer stage, age, and tumor location*T2DM, then, gender,
tumor location, cancer stage, age, cancer stage*T2DM and finally, gender, tumor
location, cancer stage, age, and age*T2DM. Finally, I conducted a multivariable-adjusted
Cox regression analysis stratified by these four covariates. To build the models, I fitted
T2DM plus the respective stratum covariate (model 1). Model 2 included model 1 and all
other potential effect modifiers (body mass index, drinking status, smoking status, family
history of CRC).
The Kaplan Meier plots for gender are shown in figure 4 and figure 5. Similar
plots were generated for age group, tumor location and cancer stage. The result of the
stratified log rank tests for the variables is as shown in Table 11. The p values for all the
covariates were not statistically significant, meaning that there are no statistically
significant differences among the strata with regards to the association between T2DM
and CRC. The Wald P values for these interaction terms were not statistically significant
(Table 12). The hazard ratios and corresponding 95% confidence intervals for different
strata of the covariates from the multivariate Cox proportional models are shown in
Tables 13 to 16. These results demonstrated that across strata of gender, age group, tumor
location and cancer stage, controlling for confounding variables, there are no statistical
significance difference in survival rates between CRC cases with T2DM and those
without T2DM. Therefore, I fail to reject the null hypothesis.
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Figure 4. Kaplan Meier survival functions for males.
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Figure 5. Kaplan Meier survival functions for females
Table 11
Log Rank test of equality for differences in survival in strata of potential confounders
Variable

Chi-Square

df

p-value

Male

0.18

1

0.67

Female

0.09

1

0.77

Gender

Table continues
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Variable

Chi-Square

df

p-value

≤ 60

0.01

1

0.94

≥ 61

0.58

1

0.45

Localized

0.06

1

0.81

Regional

0.00

1

0.97

Distant

0.03

1

0.86

Colon

2,59

1

0.11

Rectum

2.69

1

0.10

Age Group

Cancer Stage

Tumor Location

Test of equality of survival distributions for the different levels of predictor variables
Table 12
Multivariable-adjusted models with interaction terms

Model

Variable

Wald

P

Model 1

T2DM*gender

0.00

0.96

Model 2

T2DM*tumor location

1.13

0.29

Model 3

T2DM*cancer stage

0.20

0.91

Model 4

T2DM*age group

0.21

0.65

Note. Variables included in each model: gender, tumor location, cancer stage and age
group
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Table 13
Multivariable-adjusted association between T2DM and CRC by gender

Male

Female

HR

95% CI

P

HR

95% CI

P

Model 1

0.87

0.45-1.67

0.60

0.91

0.47-1.70

0.77

Model 2

1.06

0.53-2.13

0.60

0.96

0.49-1.87

0.91

Note Referent = noT2DM
Table 14
Multivariable-adjusted association between T2DM and CRC by age group

≤60years

≥ 61 years

HR

95% CI

P

HR

95% CI

P

Model 1

0.75

0.36-1.57

0.45

0.98

0.54-1.77

0.90

Model 2

1.08

0.47-2.48

0.86

1.13

0.61-2.08

0.71

Note. Referent = noT2DM
Table 15
Multivariable-adjusted association between T2DM and CRC by tumor location

Colon

Rectum

HR

95% CI

P

HR

95% CI

P

Model 1

0.62

0.34-1.12

0.11

1.85

0.87-3.91

0.11

Model 2

0.83

0.44-1.57

0.60

1.50

0.68-3.31

0.31

Note. Referent = noT2DM

101
Table 16
Multivariable-adjusted association between T2DM and CRC by cancer stage 14

Local

Regi

Distant

on
HR

95% CI

P

HR

95%CI

P

HR

95% CI

P

Model 1

1.20

0.27-5.42

0.81

0.98

0.42-2.30

0.99

1.05

0.58-.90

0.8

Model 2

3.73

0.24-6.30

0.34

1.02

0.40-2.59

0.97

1.02

0.55-.90

0.5

Note. Referent = noT2DM
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Summary
The purpose of this retrospective quantitative research was to examine the
association between T2DM and the risk of developing CRC as well as the association
between T2DM and survival rates of CRC in Oman while controlling for the potential
confounding variables diet, BMI, physical activity, alcohol consumption, smoking status,
age, and family history. Stage of disease and tumor location was additionally adjusted for
in models for survival analysis. Analysis of the two data sets provided by the Sultan
Qaboos University Hospital (SQUH) enabled testing the hypotheses, and answering the
research questions. The following null hypotheses were tested.
H01: There is no association between T2DM and CRC risk in Oman
H02: There is no association between T2DM and survival rates in CRC in Oman.
H03: There are no differences in the association between T2DM and CRC survival
rates in categories defined by gender, age group, tumor location and cancer stage in
Oman.
Based on the findings from the analyses, none of the three null hypotheses could
be rejected.
To answer Research Question 1, multivariable-adjusted logistic regression was
carried out to test the association between T2DM (the independent variable) and odds of
developing CRC (the dependent variable). The results of the multivariable- adjusted
analysis indicated there was no statistically significant association between T2DM and
odds of developing CRC (OR = 1.49, 95% CI: 0.29-7.68, p = 0.64); therefore, the null
hypothesis was not rejected.
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For Research Question 2, Kaplan Meier curves for CRC patients with T2DM and
those without T2DM were generated and compared. The median survival for CRC
patients with T2DM was 113.2 months compared to 115.2 months for those without
T2DM. The log-rank test, χ2 (1) = .239, p = 0.625 was not statistically significant. The
multivariable-adjusted Cox regression analysis was not statistically significant (HR =
1.07, 95%CI: 0.65-1.75, p = 0.80) therefore; the null hypothesis of no association
between T2DM and CRC survival rates in Oman was not rejected.
For Research Question 3, a stratified Kaplan Meier survival analysis was
conducted across strata of gender, age group, tumor location and cancer stage
respectively. The result of the log rank test of equality of differences in survival rates by
T2DM status showed no statistically significant differences across all strata of the
variables. The hazard ratios and corresponding 95% confidence intervals for the different
strata of the covariates from the multivariate Cox proportional hazards models were not
statistically significant (male, HR = 1.09, 95% CI: 0.52-2.20, p = 0.83, female: HR =
1.00, 95% CI: 0.51-1.98, p = 0.99; age group: ≤ 40, HR = 0.83, 95% CI: 0.16-4.39, p =
0.88, 41-60, HR = 1.36, 95% CI: 0.67-2.75, p = 0.39, ≥ 61, HR = 1.03, 95% CI: 0.442.40, p = 0.96, tumor location: colon, HR = 0.93, 95% CI: 0. 48-1.79, p = 0.82, rectum,
HR = 1.29, 95% CI: 0.57-2.93, p = 0.54, cancer stage: local, HR = 2.25, 95% CI: 0.1148.50, p = 0.60, regional, HR = 1.09, 95% CI: 0.42-2.80, p = 0.86, distant, HR = 1.07,
95% CI: 0.57-2.05, p = 0.80). Therefore, the null hypothesis of no differences in the
association between T2DM and CRC survival, in strata of gender, age group, tumor
location and cancer stage could not be rejected.
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In Chapter 5 there will be an in-depth interpretation of the findings from this
study with the view to place them within the larger body of literature presented in
Chapter 2. A review of the study’s limitations, recommendations for further research, and
the implication for social change will also be discussed.
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Chapter 5: Discussion, Conclusions, and Recommendations
Introduction
In this retrospective, quantitative study, I examined the association between
T2DM and the risk and survival rates of CRC in Oman while controlling for stage of
disease, gender, diet, BMI, physical activity, alcohol consumption, smoking, age, and
family history of CRC. The ecosocial theory guided this study. The hypotheses and
research questions were addressed using the data provided by the SQUH. In this chapter,
I will summarize the key findings of this research study, provide an interpretation of the
findings in relation to the existing literature, and highlight some of the study limitations.
This will be followed by a series of recommendations for further research and action, a
discussion about the social change implications of the research findings, and conclusions.
Summary of Findings
I employed logistic regression analysis to answer Research Question 1 and Cox
proportional hazard regression analysis to answer Research Questions 2 and 3. In
Research Question 1, it was hypothesized that T2DM is associated with higher odds of
developing CRC. In Research Question 2, I hypothesized that there is an association
between T2DM and CRC survival rates, while for Research Question 3, it was
hypothesized that the association between T2DM and CRC survival is different in
categories defined by gender, age group, tumor location, and cancer stage.
The independent variable in this study, T2DM, had no statistical significance and
was not associated with an increase in the odds of developing CRC (OR = 1.49, 95% CI:
0.29-7.68, p = 0.64), neither was it associated with poorer CRC survival rates (HR = 1.07,
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95% CI: 0.65 -1.75, p = 0.80). In the analyses stratified by gender, age group, tumor
location, and cancer stage, T2DM was also not statistically significantly associated with
CRC survival ( gender: male, HR = 1.09, 95% CI: 0.52-2.20, p = 0.83, female: HR =
1.00, 95% CI: 0.51-1.98, p = 0.99; age group: ≤ 40, HR = 0.83, 95% CI: 0.16-4.39, p =
0.88, 41-60, HR = 1.36, 95% CI: 0.67-2.75, p = 0.39, ≥ 61, HR = 1.03, 95% CI: 0.442.40, p = 0.96, tumor location: colon, HR = 0.93, 95% CI: 0. 48-1.79, p = 0.82, rectum,
HR = 1.29, 95% CI: 0.57-2.93, p = 0.54, cancer stage: local, HR = 2.25, 95% CI: 0.1148.50, p = 0.60, regional, HR = 1.09, 95% CI: 0.42-2.80, p = 0.86, distant, HR = 1.07,
95% CI: 0.57-2.05, p = 0.80).
Interpretation of Findings
T2DM and Risk of Developing CRC
In Research Question 1, I asked if there was an association between T2DM and
the risk of developing CRC. I found that having adjusted for potential confounding
variables, there was no statistically significant association between T2DM and higher
odds of CRC. Therefore, the null hypothesis could not be rejected. This finding
contradicts the results of similar previous studies on the association between T2DM and
the odds of developing CRC (L. Chen et al., 2013; Levi et al., 2002; Seow et al., 2006).
L. Chen et al. reported overall higher odds of CRC in T2DM cases compared to controls.
Levi et al. conducted a retrospective case control study on a sample of 836 Swiss men
and women and found that, compared to those without a history of T2DM, participants
with T2DM had almost two-fold odds of developing CRC. On the other hand, Seow et al.
used a prospective study design to examine the association between a history of T2DM

107
and CRC among a sample of the ethnic Chinese population of Singapore and found a
50% higher risk of developing CRC in diabetics compared to nondiabetics.
The study results on the association between T2DM and CRC, irrespective of
study design, were generally inconsistent (Campbell et al., 2010; Chodick et al., 2010;
Jarvandi et al., 2013; Yuhara et al., 2011). Campbell et al., (2010) found increased odds
of developing CRC was found in men but not in women; whereas, Chodick et al. found
an increased risk in women with T2DM but not in men. On the other hand, Jarvandi et al.
(2013) found an association between T2DM and odds of developing cancer for proximal
but not distal colon while Yuhara et al. (2011) reported a significant association for distal
colon but not for rectal subsite. Therefore, this retrospective quantitative study, the first to
examine the association between T2DM and CRC among an Arab population, adds to the
literature on the association between T2DM and the risk of developing CRC and warrants
further studies.
T2DM and Survival Rates of CRC
In Research Question 2, I asked if there was any association between T2DM and
CRC survival rates in Oman. I found that the association was not statistically significant;
therefore, the null hypothesis was not rejected. This finding is in conformity with the
studies of Noh et al. (2010), Morrison et al. (2011), and Ahmadi et al. (2014). Ahmadi et
al. found no significant difference in median survival time between CRC patients with
T2DM compared to those without T2DM. Similarly, Noh et al. did not find any relation
between the presence of T2DM and CRC survival or recurrence. The authors called for
more studies to elucidate whether the presence of T2DM truly contributed to poorer
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survival in CRC cases. Ahmadi et al. suggested future scholars can examine if survival of
CRC patients was dependent on other factors such as stage of disease at diagnosis and not
necessarily on T2DM. However, in this present study, I found no association between
T2DM and CRC survival rates by categories of stage of disease.
Contrary to the findings in this research, some authors (Dehal et al., 2012; Huang
et al., 2011; Van de Poll-Franse et al., 2012) found that T2DM was associated with
poorer CRC survival rates. However, Huang et al. (2011) did not differentiate between
types of DM even though the mechanism by which both types of diabetes cause cancers
may differ (Shu et al., 2010). Further studies on participants with T2DM were warranted.
Although I focused on CRC cases with T2DM, I found no association between T2DM
and CRC survival rates. Similar to my study, Van de Poll-Franse et al. (2012) did not
have information about the diabetes duration, insulin use, as well as metformin use.
Insulin use has been shown to negatively impact CRC survival (Chang et al., 2012).
Further studies about the association between T2DM and CRC can overcome these
limitations. Onitilo et al. (2012b) acknowledged that the association between T2DM is an
ongoing debate, and they argued that glycemic influences on CRC survival rates
observed in some studies may be an indirect reflection of the complexities of managing
CRC patients with T2DM, such as offering less aggressive treatments to CRC patients
with T2DM. This nonstatistically significant association between T2DM and CRC
survival in the current study adds to the body of existing literature and warrants further
studies.
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T2DM/CRC Survival Rates by Gender, Age, Tumor Location, and Cancer Stage
In Research Question 3, I asked if the association between T2DM and CRC
survival was different in categories defined by gender, age group, tumor location, and
cancer stage.
In the multivariable-adjusted Cox proportional hazards regression result, I found
that across strata of gender, age group, tumor location, and cancer stage, there were no
statistically significant differences in survival rates between CRC cases with T2DM and
those without T2DM. Therefore, the null hypothesis was not rejected. Similar results
were obtained by Dehal et al. (2012), who found that though in general, cancer patients
who had T2DM had a significantly increased risk of dying from a cancer compared with
those who did not have T2DM; there were no significant differences by sex. Rudolph et
al. (2014) found that there was no survival advantage in the association between T2DM
and CRC survival by sex.
With regards to age group, the natural aging process, plus comorbid conditions
that tend to occur more with advancing age, may modify any observed association
between T2DM and CRC survival differently. Moreover, advanced age is an independent
risk factor for mortality (Morrison et al., 2011). Age did not confound the association
between T2DM and CRC survival in this research study. Nevertheless, being the first
research of its kind in an Omani population, this finding should be interpreted with
caution until replicated in future studies.
Tumor location did not influence the association between T2DM and CRC. This
finding did not align with previous studies (Jeon et al., 2013; Van de Poll-Franse et al.,
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2012),). In the study by Jeon et al. (2013), a positive association was found between
T2DM and colon specific survival but, a non-significant association was found with
rectal cancer survival. Contrary to this finding, the study by Van de Poll-Franse et al.,
(2012), reported poor survival in rectal cancer patients with T2DM and a non- significant
association between T2DM and colon cancer survival. Jeon et al. (2013) opined that the
observed differences in survival by tumor subsite may be related to the potential
mechanisms by which T2DM affects the different subsites in CRC patients. These
mechanisms are related to distinct differences in anatomy, embryology, physiology and
genetics between the colon and rectal subsites (Jeon et al., 2013). My research utilized
archival data which had no information on these variables mentioned by Jeon et al.,
(2013). Their suggestion could therefore not be verified.
The finding about cancer stage did not align with the results of the study by Gross
et al. (2006), which reported a five-year survival rate of 78.3% in stage 1 CRC disease
with no T2DM compared to 71% survival rate in patients with similar CRC stage with
comorbid T2DM. According to Gross et al. (2006), the combinations of chronic
conditions in an individual affect CRC survival to different degrees and may contribute to
poor survival. The authors advocated for more empirical investigation to elucidate how
cancer stage affect the association betweenT2DM and CRC survival. Comorbid chronic
conditions were not considered as potential confounders in this study, therefore, it was
not possible to elucidate how such chronic conditions could have influenced the
association between T2DM and CRC in this population. Nevertheless, this research
study, being the first in an Arab population, has provided baseline information that
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further studies can build upon to better understand the association between T2DM and
CRC in this population..
Limitations of the Study
The limitations of this study include selection bias, information bias and recall
bias. External validity was also a limitation. Selection bias occurs when the group studied
varies significantly from the general population. A particular selection bias that is
inherent in hospital-based case control studies is the Berkson’s bias (hospital-patient
selection bias). Berkson’s bias is a systematic bias in the distribution of disease amongst
hospitalized patients such that in case-control studies where both cases and controls are
selected from the hospital, the controls tend to be more likely exposed to the exposure
under consideration than the general population from which the cases came from
(Schwartzbaum et al., 2003; Roberts et al., 1978). When Berkson’s bias occurs, the odds
ratio tends to be underestimated.
The dataset that addressed research question1 was a hospital based case-control
study. According to Schwartzbaum et al., (2003), Berkson’s bias can be reduced in
hospital-based case control studies by choosing hospital controls from among patients
admitted to the hospital for conditions that are unrelated to the case disease. Furthermore,
cases should be admitted in the hospital for reasons unrelated to the exposure. In this
study, controls were chosen from among patients admitted into the ENT, orthopedic
surgery and ophthalmology departments for a wide range of acute nonmalignant
conditions. Moreover, the cases were in the hospital for reasons unrelated toT2DM, the
exposure disease. The cases were interviewed during their oncology outpatient visit or
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while they were admitted in the oncology wards for their cancer management. Therefore,
the potential for Berkson’s bias in this study is minimized.
This study used data from one of two hospitals that treat cancers in Oman.
Although SQUH treats about 65% of cancer cases in Oman, it is possible that those 35%
not captured in this study differed significantly from the participants. Therefore, the
findings from this research may not be representative of the general population in Oman.
However, a review of the demographic characteristics of the study sample in Table 4
showed that the male/ female ratio is 1.42, similar to the male/female ratio in the general
Omani population (World Population Review, 2016.).
The relatively small sample size used in this study compared to studies done in
other populations may have affected the findings. Morrison et al., (2011), stated that the
relationship between T2DM and CRC is most clearly seen in bigger samples with higher
prevalence (above 20%) of T2DM. The prevalence of T2DM in the Omani population is
15% (IDF, 2015). Nevertheless, the minimum sample sizes necessary to reject the null
hypotheses in this study were obtained by two different types of sample size calculators
namely, the OpenEpi software version 3.1.9.2 (Dean et al., 2009) and the PS power
software (Dupont & Plummer, 1990). This study was also limited to the population of
Oman and may not be generalized to other non-Arab populations.
In the sample that was used to answer Research Question 2 and 3, information on
diet and physical activity status was only available for 42 cases. A subgroup analysis
could not be conducted with this sample of 42 cases due to the small sample size.
Therefore, it was not possible to examine how diet and physical activity could have
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affected the results. The latest WCRF report on diet, nutrition, physical activity and CRC
states that there is strong evidence that physical activity, consuming diets of whole grains
fiber and dairy products reduce the risk of developing CRC whereas consumption of red
and processed meat and excess body fat increases the risk (WCRF, 2017). The WCRF
recommends that to reduce risk of developing CRC, individuals should take steps to eat
healthy diet, maintain healthy body weight and minimize alcohol intake Similar
recommendations are stipulated in the AICR guideline for CRC prevention (AICR, 2016)
The absence of diet and physical activity information in this study was a major limitation
therefore, caution should be applied in the interpretation the results.
Information exposure misclassification and recall bias may also have occurred in
this study. Information bias arising from misclassification of exposure status of
participants, wrong definition of study variables, as well as faulty data collection
technique are some of the internal validity threats in case-control studies (Szklo, & Nieto,
2014, Pp. 117-130). For example, this study used data collected on an intervieweradministered food frequency questionnaire to answer Research Question 1. Participants
were asked questions about their T2DM status in addition to questions about their diet
before the diagnosis of their cancer. It is possible participants did not correctly recall their
T2DM status. However, this limitation was overcome by verifying self-reported T2DM
status from a review of patients’ case histories and drug summaries. Secondly, the
participants may not have correctly recalled their diet habits which may have resulted in
misclassification of cases with regards to their diet. Moreover, information bias would
also occur if participants were not honest enough in their responses to questions on
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alcohol consumption and smoking. The question about alcohol consumption is
particularly sensitive given that Oman is a Muslim country where alcohol consumption is
prohibited. The presence of information bias in this study may have biased the results
towards the null. Finally, this study was an observational study therefore, cause and effect
could not be determined (Creswell, 2009), plus, other unknown confounders could have
also affected the findings.
Recommendations for Action
In this quantitative retrospective study, T2DM was not associated with higher
odds of developing CRC, neither was it associated with poorer CRC survival rates.
Nevertheless, the high prevalence of T2DM and other established CRC risk factors such
as obesity in the Omani population (Al Riyami, 2010; Al Nohair, 2014; WHO, 2015),
calls for proactive action among stakeholders. On the part of the researchers, more
studies should be conducted with a more representative sample. The responsibility of the
Omani government would be to support country-wide health education programs about
weight reduction and, screening and early detection targeted at groups at risk of both
T2DM and CRC. Health care professionals can also take action to educate people on how
to minimize their risk of developing CRC by being physically active, consuming diets
rich in fiber, whole grains and dairy products and, to cut down on consumption of red and
processed meat and, alcoholic beverages as recommended by the WCRF and the AICR.
Public health education should also include information on how to recognize CRC
symptoms and seek help early in order to improve CRC survival outcomes.
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Recommendations for Further Study
The sample for this research was drawn from the population of CRC patients that
attended one of two hospitals that treat CRC cases in Oman. A similar study could be
conducted with sample from both hospitals. Such study would be more representative
than this current study. A study with a bigger sample size could help to better understand
the association between T2DM and CRC in Oman. Moreover, this study was
retrospective in nature. Although it provided data on the variables of interest in this study
at low cost, a nationwide prospective study with collaboration between the two centers
that treat all malignancies in Oman can be undertaken to better elucidate the true
association between T2DM and CRC in the Omani population.
The archival data that was used to address Research Question 2 and 3 did not
contain data on diet and physical activity status of the participants. Given the
recommendations from international health organizations such as the WCRF and the
AICR about the importance of diet, physical activity and the need to maintain a healthy
bodyweight in reducing the risk of CRC, a more robust study that includes information
on diet and physical activity as well as all potential risk factors and effect modifiers of the
association between T2DM and CRC is warranted.
In this study, BMI was calculated from participants’ medical records as weight in
kilograms divided by the square of height in meters (kg/m2). However, studies have
shown that BMI studies based on self-reported measurements and retrospective chart
reviews tend to be imprecise (Gurunathan, & Myles, 2016). Future studies in which BMI
is prospectively derived by trained personnel are more likely to yield accurate values and
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should be considered. Better still, future studies should consider using waist
circumference which is a more accurate measure of visceral fat as an indicator of
overweight and obesity (Gurunathan, & Myles, 2016). Lastly, the classification of the
exposure variable T2DM was based on self-reported response in the intervieweradministered questionnaire, as well as chart reviews. Future studies whereby diabetes
status is determined by laboratory values of blood sugar levels will more likely yield
accurate results, and should be conducted.
Implications for Social Change
The social change implication of this study is about informing preventive
strategies for reducing the burden of CRC in Oman. This study filled a gap in the
literature in that it is the first of such study in an Arab population. Although the study did
not find any association between T2DM and CRC risk and survival, the findings could
generate interest for more of such studies in this population. Results from such studies
could build on the findings from this current research to better inform preventive
strategies to lower the burden of CRC in Oman. The literature review that informed this
research pointed to possible links between T2DM and other covariates, and CRC.
Therefore, this study may create awareness about the possible contribution of T2DM and
the other covariates explored in this study to the overall burden of CRC in Oman. This
awareness may stir policy makers into taking action around CRC risk-reduction strategies
tailored towards the Omani population. Such risk reduction programs may include public
awareness programs that encourage individuals and communities to maintain healthy
body weight and to participate in CRC screening and early detection programs. This
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could lead to a positive social change impact across the country. Moreover, positive
social change will occur when such programs create a greater self- awareness of the risk
factors for CRC among individual members of the Oman population.
Conclusions
This quantitative, retrospective study used secondary data from SQUH Oman and
found no association between T2DM and the odds of developing CRC in an Omani
population. The study also found that T2DM was not associated with CRC survival rates
in this population. CRC remains a public health problem in Oman with significant human
and healthcare costs. It is the second most common cancer in Omani males and the third
most common in females. The findings from this research could generate interest for
further studies into the risk and prognostic factors for CRC in the Omani population.
Further studies with a more representative CRC sample is recommended to build on the
findings from this research.
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Appendix A: Log-Log function for Covariates

Figure A1 Kaplan Meier Log-Log function for age group
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Figure A2 Kaplan Meier Log-Log function for stage of disease
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Figure A3 Kaplan Meier Log-Log function for gender
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Figure A4 Kaplan Meier Log-Log function for tumor location
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Figure A5 Kaplan Meier Log-Log function for BMI
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Figure A6 Kaplan Meier Log-Log function for alcohol consumption
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Figure A7 Kaplan Meier Log-Log function for smoking status
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FigureA8 Kaplan Meier Log-Log function for family history of CRC

